We've made some changes to EPA.gov. If the information you are looking for is not here, you may be able to find it on the EPA Web Archive or the January 19, 2017 Web Snapshot.

Research Grants

Long-term Exposure to Air Pollution and Development of Cardiovascular Disease

U.S. Environmental Protection Agency
Office of Research and Development
National Center for Environmental Research
Science to Achieve Results (STAR) Program

Long-term Exposure to Air Pollution and Development of Cardiovascular Disease

This is the initial announcement of this funding opportunity.

Funding Opportunity Number: EPA-G2016-STAR-B1

Catalog of Federal Domestic Assistance (CFDA) Number: 66.509

Solicitation Opening Date: May 18, 2016
Solicitation Closing Date: August 2, 2016, 11:59:59 pm Eastern Time

Technical Contact: Vito Ilacqua (ilacqua.vito@epa.gov); phone: 202-564-4512
Eligibility Contact: Ron Josephson (josephson.ron@epa.gov); phone: 202-564-7823
Electronic Submissions: Debra M. Jones (jones.debram@epa.gov); phone: 202-564-7839

Table of Contents:
SUMMARY OF PROGRAM REQUIREMENTS
  Synopsis of Program
  Award Information
  Eligibility Information
  Application Materials
  Agency Contacts
I. FUNDING OPPORTUNITY DESCRIPTION
  A. Introduction
  B. Background
  C. Authority and Regulations
  D. Specific Areas of Interest/Expected Outputs and Outcomes
  E. References
  F. Special Requirements
II. AWARD INFORMATION
III. ELIGIBILITY INFORMATION
  A. Eligible Applicants
  B. Cost Sharing
  C. Other
IV. APPLICATION AND SUBMISSION INFORMATION
  A. Grants.gov Submittal Requirements and Limited Exception Procedures
  B. Application Package Information
  C. Content and Form of Application Submission
  D. Submission Dates and Times
  E. Funding Restrictions
  F. Submission Instructions and Other Submission Requirements
V. APPLICATION REVIEW INFORMATION
  A. Peer Review
  B. Programmatic Review
  C. Human Subjects Research Statement (HSRS) Review
  D. Funding Decisions
  E. Additional Provisions for Applicants Incorporated into the Solicitation
VI. AWARD ADMINISTRATION INFORMATION
  A. Award Notices
  B. Disputes
  C. Administrative and National Policy Requirements
VII. AGENCY CONTACTS

Access Standard STAR Forms (How to Apply and Required Forms)
View research awarded under previous solicitations Past Research Funding Opportunities

SUMMARY OF PROGRAM REQUIREMENTS

Synopsis of Program:
The U.S. Environmental Protection Agency (EPA), as part of its Science to Achieve Results (STAR) program, is seeking applications proposing to expand and inform the understanding of the mechanism(s) by which air pollution contributes to the development of cardiovascular disease. Specifically, research is needed to estimate the total cardiovascular risk associated with exposure to air pollution, including indicators of early subclinical damage and novel endpoints, in addition to established morbidity and mortality outcomes.  Research is also needed to understand related endpoints such as markers of cardio-metabolic responses and cerebrovascular disease. In consideration of the implications of this research and of regulations promoting open access to federally funded data, the Agency is seeking applications that develop innovative methods for broad access to data generated in response to this solicitation.

This solicitation provides the opportunity for the submission of applications for projects that may involve human subjects research.  Human subjects research supported by the EPA is governed by EPA Regulation 40 CFR Part 26 (Protection of Human Subjects).  This includes the Common Rule at subpart A and prohibitions and additional protections for pregnant women and fetuses, nursing women, and children at subparts B, C, and D.  Research meeting the regulatory definition of intentional exposure research found in subpart B is prohibited by that subpart in pregnant women, nursing women, and children.  Research meeting the regulatory definition of observational research found in subparts C and D is subject to the additional protections found in those subparts for pregnant women and fetuses (subpart C) and children (subpart D).  All applications must include a Human Subjects Research Statement (HSRS, as described in Section IV.C.5.c of this solicitation), and if the project involves human subjects research, it will be subject to an additional level of review prior to funding decisions being made as described in Sections V.C and V.D of this solicitation. Additional information can be found in Section I.A of the full announcement.

Guidance and training for investigators conducting EPA-funded research involving human subjects may be obtained here:
Basic Information about Human Subjects Research
Basic EPA Policy for Protection of Subjects in Human Research Conducted or Supported by EPA

Award Information:
Anticipated Type of Award: Grant  
Estimated Number of Awards: One (1) award
Anticipated Funding Amount: Approximately $3 million total for all awards
Potential Funding per Award: Up to a total of $3,000,000, including direct and indirect costs, with a maximum duration of 5 years.  Cost-sharing is not required.  Proposals with budgets exceeding the total award limits will not be considered.

Eligibility Information:
Public nonprofit institutions/organizations (includes public institutions of higher education and hospitals) and private nonprofit institutions/organizations (includes private institutions of higher education and hospitals) located in the U.S., state and local governments, Federally Recognized Indian Tribal Governments, and U.S. territories or possessions are eligible to apply.  See full announcement for more details.

Application Materials:
To apply under this solicitation, use the application package available at Grants.gov (for further submission information see Section IV.F. “Submission Instructions and other Submission Requirements”).  Note: With the exception of the current and pending support form (available at Research Funding Opportunities: How to Apply and Required Forms), all necessary forms are included in the electronic application package. Make sure to include the current and pending support form in your Grants.gov submission.

If your organization is not currently registered with Grants.gov, you need to allow approximately one month to complete the registration process. Please note that the registration process also requires that your organization have a unique entity identifier (formerly ‘DUNS number’) and a current registration with the System for Award Management (SAM) and the process of obtaining both could take a month or more.  Applicants must ensure that all registration requirements are met in order to apply for this opportunity through Grants.gov and should ensure that all such requirements have been met well in advance of the submission deadline.  This registration, and electronic submission of your application, must be performed by an authorized representative of your organization.

If you do not have the technical capability to utilize the Grants.gov application submission process for this solicitation, see Section IV.A below for additional guidance and instructions.

Agency Contacts:
Technical Contact: Vito Ilacqua (ilacqua.vito@epa.gov); phone: 202-564-4512
Eligibility Contact: Ron Josephson (josephson.ron@epa.gov); phone: 202-564-7823
Electronic Submissions: Debra M. Jones (jones.debram@epa.gov); phone: 202-564-7839

I. FUNDING OPPORTUNITY DESCRIPTION

A. Introduction
The effects of air pollution on the cardiovascular system account for the largest portion of the public health and economic benefits of the Clean Air Act. The evidence for these effects is based on associations observed in a number of epidemiological studies ( Mustafić et al. 2012; Hoek et al. 2013; Shah et al., 2013; Newby et al., 2014), with biological plausibility supported by numerous mechanistic investigations (Mills et al., 2009; Sun et al., 2010; Zanobetti et al., 2011). While several mechanisms are involved, chronic cardiovascular disease (CVD) is a slowly progressing condition, whose natural history develops through most of the human life span (Grundy et al., 1999; Jardim et al., 2015).  The relationship between long-term exposure to PM2.5 and cardiovascular health effects has been determined as causal (U.S. EPA, 2009; Brook et al., 2010).  However, long-term prospective studies that can inform and reduce uncertainties about the shape of the concentration-response relationship, especially at low ambient concentrations of PM2.5, or that will aid in the identification and/or further characterization of potentially at-risk groups and adult lifestages will be especially useful for public health protection strategies.  Much uncertainty remains about the effects of ozone and nitrogen oxides on cardiovascular health. Prospective studies of long-term exposure that can support or challenge an inference of causality between these gaseous air pollutants and the development of cardiovascular disease are necessary to establish a causal association. Furthermore, information of the associations with these air pollutants and other health endpoints, especially cardiometabolic, cerebrovascular, and neurological endpoints, would be informative for clinical and public health interventions.  Epidemiological analysis examining a range of effects across these health endpoints, from biomarkers of subclinical changes to fully-developed disease, in the same population can help address these research areas.

This solicitation provides the opportunity for the submission of applications for projects that may involve human subjects research.  Human subjects research supported by the EPA is governed by EPA Regulation 40 CFR Part 26 (Protection of Human Subjects).  This includes the Common Rule at subpart A and prohibitions and additional protections for pregnant women and fetuses, nursing women, and children at subparts B, C, and D.  Research meeting the regulatory definition of intentional exposure research found in subpart B is prohibited by that subpart in pregnant women, nursing women, and children.  Research meeting the regulatory definition of observational research found in subparts C and D is subject to the additional protections found in those subparts for pregnant women and fetuses (subpart C) and children (subpart D).  All applications must include a Human Subjects Research Statement (HSRS, as described in Section IV.C.5.c of this solicitation), and if the project involves human subjects research, it will be subject to an additional level of review prior to funding decisions being made as described in Sections V.C and V.D of this solicitation.

Please note that surveys, interviews, and focus groups with individuals may constitute human subjects research.

The additional level of review is conducted by the EPA Human Subjects Research Review Official (HSRRO).  In making a determination about conditional and later final approval, the HSRRO will apply both EPA Regulation 40 CFR 26 and EPA Policy Order 1000.17 Change A1, where human exposure research is interpreted as any intervention that manipulates subjects’ environment (i.e., modifies subjects’ exposure).

For more specific information including guidance and training, see:
Basic Information about Human Subjects Research
Basic EPA Policy for Protection of Subjects in Human Research Conducted or Supported by EPA

EPA recognizes that it is important to engage all available minds to address the environmental challenges the nation faces. At the same time, EPA seeks to expand the environmental conversation by including members of communities which may have not previously participated in such dialogues to participate in EPA programs. For this reason, EPA strongly encourages all eligible applicants identified in Section III, including minority serving institutions, to apply under this opportunity.

For purposes of this solicitation, the following are considered MSIs:

  1. Historically Black Colleges and Universities, as defined by the Higher Education Act (20 U.S.C. § 1061). A list of these schools can be found at White House Initiative on Historically Black Colleges and Universities;
  2. Tribal Colleges and Universities, as defined by the Higher Education Act (20  U.S.C. § 1059(c)). A list of these schools can be found at American Indian Tribally Controlled Colleges and Universities;
  3. Hispanic-Serving Institutions (HSIs), as defined by the Higher Education Act (20 U.S.C. § 1101a(a)(5). There is no list of HSIs. HSIs are institutions of higher education that, at the time of application submittal, have an enrollment of undergraduate full-time equivalent students that is at least 25% Hispanic students at the end of the award year immediately preceding the date of application for this grant; and
  4. Asian American and Native American Pacific Islander-Serving Institutions; (AANAPISIs), as defined by the Higher Education Act (20 U.S.C. § 1059g(a)(2)). There is no list of AANAPISIs. AANAPISIs are institutions of higher education that, at the time of application submittal, have an enrollment of undergraduate students that is not less than 10 % students who are Asian American or Native American Pacific Islander.

B. Background
The mechanism by which air pollution contributes to the pathophysiology of CVD is complex and not yet completely understood. Evidence is accumulating for PM2.5 (Mills et al. 2009; Forastiere and Agabiti, 2013) regarding a cascade of events triggered by inhalation of fine particles that results in oxidative stress and inflammation, and continues in altered endothelial, thrombotic, and autonomic function, as well as promotion of atheroma.  In addition to oxidative stress, direct central nervous system activation may be implicated as well, with further consequences for rhythm control. Several of these mechanisms are important for acute CVD morbidity and mortality in people with chronic CVD, but a critical public health question is whether exposure to air pollution is a contributing risk factor for the development of CVD in a healthy population, as the resulting burden of disease of air pollution could be substantially larger than is currently estimated. Less is known about the mechanism by which long-term exposure to gaseous pollutants may contribute to CVD and other health endpoints, especially cardiometabolic, cerebrovascular, and neurological endpoints, or the mechanisms by which co-exposures to gaseous pollutants may modify the effects of PM2.5 on CVD. 

The concept of premature vascular aging has been proposed as a framework to estimate burden for the transition between healthy and subclinical status (Adar et al. 2010; Kuenzli et al. 2011; Krishnan et al. 2012). A few toxicological (Sun et al., 2005; Araujo et al., 2008) and epidemiological studies (Kuenzli et al. 2005; Bauer et al. 2010; Gill et. al, 2011) have examined the association between air pollution and atherosclerosis in particular, as this progressive insidious disease is the leading cause of mortality worldwide (Barquera et al., 2015), a trend that is anticipated to continue (Fonarow, 2007). New research that can be readily integrated and synthesized into this existing, multi-disciplinary body of literature will be especially informative.

To fully characterize the relationship between exposure to air pollution and subclinical development of CVD (and other health endpoints), knowledge of the concentration-response relationship at low ambient concentrations is critical to formulate public health strategies (state and local regulation and implementation, behavioral, clinical) that manage risk appropriately (Pope et al., 2015). As the link between air pollution and incidence of subclinical CVD (rather than its clinical endpoints) remains poorly understood, so is the form of its concentration-response relationship. A few estimates of concentration-response relationships have been formulated to assess the burden of CVD morbidity and mortality attributable to air pollution (Schwartz & Zanobetti, 2000; Aunan & Pan, 2004; Pope et al., 2009; Burnett et al., 2014). These estimates of concentration-response relationships have greater precision where there is the most information on population exposures.  In most cases, this has been at higher levels of exposure, although studies in locations with generally lower PM2.5 concentrations are becoming more prevalent in developed countries (Crouse et al, 2015).  While some studies at low concentrations are now being conducted, substantial uncertainty remains at concentrations near or below current air quality standards that are experienced by a majority of the population in developed countries (Shin et al., 2015). More information is needed at these ambient concentrations particularly in light of the apparent supralinear relationships at low concentrations of PM2.5 suggested in some of these estimates (Pope et al., 2015, Nasari et al, 2016). Exploration of nonlinear relationships is also especially needed to evaluate risk in realistic exposure scenarios that involve multipollutant interactions (Oakes et al., 2014; Zanobetti et al., 2014).

Historically, the effects of short- and long-term exposures to air pollution have been considered separately, with different risk estimates associated with acute and chronic morbidity and short- and long-term mortality effects (Schwartz, 2000; Zanobetti et al, 2003; Pope & Dockery, 2006). This paradigm, shared with analyses of risk for other environmental pollutants, has been driven both by physiological understanding of the mechanisms of action and by limited availability of reliable data for exposure assessment. With the accumulation of air quality monitoring data that allows better retrospective exposure assessment for longer time-series analyses, it may be possible now to explore how health effects are associated with different aspects of exposure, including cumulative of exposures, latency between exposure and health response, and a  continuum of exposure durations. For cardiovascular disease with variable progression rates during a lifetime, such as atherosclerosis (Kiechl et al., 1999), analyses of association at different long-term time scales could provide valuable information to estimate the fraction of attributable burden from subclinical disease development (perhaps over several decades) and the fraction of burden from clinical manifestations of the disease (perhaps over several years). New research that evaluates health effects due to past and recent long-term exposures and that improves the understanding of the relevant latency period will be informative. Aside from the public health value of understanding burden of disease, the analysis could provide insights for prevention and clinical management for people at different stages of disease. The evaluation of effect modification can contribute to the identification and characterization of potentially at-risk populations and adult lifestages.  New research that evaluates effect modifiers (e.g., pre-existing disease, race/ethnicity, sociodemographic and behavioral factors) will be informative.

Regardless of exposure duration and concentration, exposure misclassification has long been recognized as an inherent limitation of air pollution epidemiology (Zeger et al., 2000). Spatial misalignment of exposure measurements can occur when fixed monitoring data are used for spatially heterogeneous pollutants, while attempts to model personal exposures from limited microenvironmental information can introduce additional error. A variety of methods and approaches for air pollution exposure has been evaluated (Jerrett et al., 2005; Szpiro et al., 2010; Sheppard et al., 2012; Ozkaynak et al., 2013), especially to correct biases towards null results. Yet, it is important to advance the exposure science and understanding to clearly separate the effects that exposure modeling assumptions and choices have on estimated health effects from those they have on error estimates themselves. Such analyses would allow consideration of the advantages and disadvantages of model complexity independently of assumptions about health effects of exposures (Baxter et al., 2013; Dionisio et al., 2015).

Studies that make critical contributions to the body of evidence supporting public health policy and clinical practice deserve a correspondingly high level of scrutiny, which can be best ensured by independent verification of their conclusions. To that end, ensuring verification and reproducibility requires accessibility of data to other qualified researchers, over a period of time that extends well beyond the publication of results. While regulatory requirements exist for sharing data from publicly funded research, these are focused on awardee responsibilities that are necessarily limited in time and scope, rather than on solutions that actively facilitate access by independent investigators. Additionally, data that contain geospatial information, as much air pollution exposure data do, are simultaneously subject to regulations intended to protect the privacy of participants in a research project. The debate around the perceived conflict between these requirements (Wartenberg and Thompson, 2010; Rothenstein, 2010; Vayena et al., 2015, etc.) is made more acute by growing demand for direct citizen access to the science underpinning public and environmental health protection. Some methods may exist to anonymize geospatial data without loss of exposure-relevant information (Rodgers et al. , 2012; Kounadi and Leitner, 2016), but they have not been widely applied to environmental data sets, and the question of how to maximize accessibility of environmental health data while preserving researchers’ rights and participants confidentiality does not yet have satisfactory answers.

The specific Strategic Goal and Objective from the EPA’s Strategic Plan that relate to this solicitation are:

Goal 1: Addressing Climate Change and Improving Air Quality, Objective 1.2: Improve Air Quality

The EPA’s FY 2014-18 Strategic Plan can be found at: EPA Strategic Plan

C. Authority and Regulations
The authority for this RFA and resulting awards is contained in the Clean Air Act, Section 103, 42 U.S.C. 7403.

For research with an international aspect, the above statutes are supplemented, as appropriate, by the National Environmental Policy Act, Section 102(2)(F).

Note that a project’s focus is to consist of activities within the statutory terms of EPA’s financial assistance authorities; specifically, the statute(s) listed above.  Generally, a project must address the causes, effects, extent, prevention, reduction, and elimination of air pollution, water pollution, solid/hazardous waste pollution, toxic substances control, or pesticide control depending on which statute(s) is listed above.  These activities should relate to the gathering or transferring of information or advancing the state of knowledge.  Proposals should emphasize this “learning” concept, as opposed to “fixing” an environmental problem via a well-established method.  Proposals relating to other topics which are sometimes included within the term “environment” such as recreation, conservation, restoration, protection of wildlife habitats, etc., must describe the relationship of these topics to the statutorily required purpose of pollution prevention and/or control.  Note: Applications dealing with any aspect of or related to hydraulic fracking will not be funded by EPA through this program.

Applicable regulations include: 2 CFR Part 200, 2 CFR Part 1500, and 40 CFR Part 40 (Research and Demonstration Grants).

D. Specific Areas of Interest/Expected Outputs and Outcomes
Note to applicant:  The term “output” means an environmental activity, effort, and/or associated work products related to an environmental goal or objective, that will be produced or provided over a period of time or by a specified date.  The term “outcome” means the result, effect or consequence that will occur from carrying out an environmental program or activity that is related to an environmental or programmatic goal or objective.

The Agency is soliciting research to expand and increase the understanding of the evidence for the associations between air pollution and cardiovascular disease and other related health endpoints. Specifically, research is needed to estimate the total cardiovascular risk associated with exposure to air pollution, including indicators of early subclinical damage and novel endpoints, in addition to established and emerging morbidity and mortality outcomes (e.g., cardiometabolic disease, cerebrovascular disease, and neurological disease).

This research may take the form of epidemiological analyses of standardized CVD morbidity and mortality measures, or of subclinical physiological changes, associated with exposure to air pollution; or characterizations of the concentration-response relationship between air pollution and health endpoints across a range of exposure levels, including those in areas in attainment of current air pollution standards; or of alternative analyses that would produce similar outputs and outcomes.

Outputs expected from this solicitation may include publications of research results in peer-reviewed journals, among others, as well as state monitoring and implementation plans that reflect the effects of exposure measurement uncertainty and pollutant interactions. These outputs can be used to achieve public health protection outcomes (e.g. increase in public and physician awareness of lifestyle risks and prevention choices) that take into account the full benefit of improved air quality.

This RFA solicits proposals that should address at least three of the following research areas:

  1. What are the associations between health endpoints and exposure to air pollution in a well-characterized study population, including consideration of subclinical cardiovascular damage, such as atherosclerotic lesions, as well as other novel cardiovascular, cardio-metabolic, cerebrovascular, or neurological endpoints?
  2. What is the shape of the concentration-response relationship for PM2.5 and gaseous air pollutants, including NO2 and O3, and the development of health endpoints, particularly at concentrations below the levels of the current air pollution standards? How are these relationships affected by regional, socioeconomic, and comorbidity differences, and exposure to other air pollutants?
  3. What is the relative burden, along a continuum of durations, of more recent (years) long-term exposures vs. historical (decades) exposure on the association between health endpoints and air pollution?  Specifically, what are the health effects associated with cumulative exposures during adult life stages, recognizing that early exposures may have greater or lesser impacts compared with later exposures (reflecting latency of disease), and that age range during exposures may also modify the impact of exposures?
  4. What is the impact of exposure measurement error on the health effect estimation, and what is the sensitivity of both effect and error to exposure assumptions?

Proposals which do not address at least three of the research areas above may not be rated as highly under the evaluation process described in Section V.  Also, proposals that address all four of the research areas above will not necessarily be rated more highly than those that address at least three of the areas.

This RFA encourages innovative methods for access to data.  Desirable data management characteristics, that would enhance a proposal, may include, for example:

  • Innovative data sharing approaches used to increase the accessibility of geospatial exposure data to remain responsive to inquiries, while maintaining participant confidentiality, even when a collaborative approach is not feasible.
  • Ensuring the availability of the entire data set to other qualified researchers, to promote independent re-analysis and extension of results. (e.g., see HEI re-analyses and extension of ACS data, Krewski et al., 2009).  Options extending availability for an indefinite period are especially encouraged.
  • Developing a plan to leverage use of this data with other datasets, specifically promoting linking exposure estimates with other health endpoints, and comparison with other epidemiological data sets.
  • Developing provisions to respond to requests for data sets without Personally Identifiable Information, and unprocessed data as collected.

To the extent practicable, research proposals must embody innovation.  Innovation for the purposes of this RFA is defined as the process of making changes; a new method, custom or device.  Innovative research can take the form of wholly new applications or applications that build on existing knowledge and approaches for new uses.  Research proposals must include a discussion on how the proposed research is innovative (see Section IV.C.5.a).  ORD will draw from the above-mentioned innovation definition in the review/evaluation process of recommending research proposals (see Section V.A).

E. References

Adar, S. D., Klein, R., Klein, B. E., Szpiro, A. A., Cotch, M. F., Wong, T. Y., ... & Daviglus, M. L. (2010). Air pollution and the microvasculature: a cross-sectional assessment of in vivo retinal images in the population-based Multi-Ethnic Study of Atherosclerosis (MESA). PLoS Med7(11), e1000372.

Araujo, J. A., Barajas, B., Kleinman, M., Wang, X., Bennett, B. J., Gong, K. W., ... & Nel, A. E. (2008). Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circulation research102(5), 589-596.

Aunan, K., & Pan, X. C. (2004). Exposure-response functions for health effects of ambient air pollution applicable for China–a meta-analysis.Science of the Total Environment329(1), 3-16.

Barquera, S., Pedroza-Tobías, A., Medina, C., Hernández-Barrera, L., Bibbins-Domingo, K., Lozano, R., & Moran, A. E. (2015). Global overview of the epidemiology of atherosclerotic cardiovascular disease. Archives of medical research46(5), 328-338.

Bauer, M., Moebus, S., Möhlenkamp, S., Dragano, N., Nonnemacher, M., Fuchsluger, M., ... & Jöckel, K. H. (2010). Urban particulate matter air pollution is associated with subclinical atherosclerosis: results from the HNR (Heinz Nixdorf Recall) study. Journal of the American College of Cardiology,56(22), 1803-1808.

Baxter, L. K., Dionisio, K. L., Burke, J., Sarnat, S. E., Sarnat, J. A., Hodas, N., ... & Kumar, N. (2013). Exposure prediction approaches used in air pollution epidemiology studies: key findings and future recommendations. Journal of Exposure Science and Environmental Epidemiology23(6), 654-659.

Brook, Robert D., et al. "Particulate matter air pollution and cardiovascular disease an update to the scientific statement from the American Heart Association." Circulation 121.21 (2010): 2331-2378.

Burnett, R. T., Pope III, C. A., Ezzati, M., Olives, C., Lim, S. S., Mehta, S., ... & Anderson, H. R. (2014). An integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure. Environmental Health Perspectives (Online)122(4), 397.

Crouse, D.L., Peters, P.A., Hystad, P., Brook, J.R., van Donkelaar, A., Martin, R.V., Villeneuve, P.J., Jerrett, M., Goldberg, M.S., Pope, C.A. III, Brauer, M., Brook, R.D., Robichaud, A., Menard, R., Burnett, R.T. (2015). Ambient PM2.5, O3, and NO2 Exposures and Associations with Mortality over 16 Years of Follow-Up in the Canadian Census Health and Environment Cohort (CanCHEC). Environ Health Perspectives. 123(11), 1180-6.

Dionisio, K. L., Baxter, L. K., Burke, J., & Özkaynak, H. (2015). The importance of the exposure metric in air pollution epidemiology studies: When does it matter, and why?. Air Quality, Atmosphere & Health, 1-8.

Fonarow, G. C. (2007). The global burden of atherosclerotic vascular disease. Nature Clinical Practice Cardiovascular Medicine4(10), 530-531.

Forastiere F, Agabiti N. Assessing the link between air pollution and heart failure. Lancet 2013;382:1008-1010.

Gill, E. A., Curl, C. L., Adar, S. D., Allen, R. W., Auchincloss, A. H., O'Neill, M. S., ... & Kaufman, J. D. (2011). Air pollution and cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Progress in cardiovascular diseases53(5), 353-360.

Grundy, S. M., Pasternak, R., Greenland, P., Smith, S., & Fuster, V. (1999). Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Journal of the American College of Cardiology34(4), 1348-1359.

Hoek, G., Krishnan, R. M., Beelen, R., Peters, A., Ostro, B., Brunekreef, B., & Kaufman, J. D. (2013). Long-term air pollution exposure and cardio-respiratory mortality: a review. Environ Health12(1), 43.

Jardim, T. V., Sousa, A. L. L., Povoa, T. I. R., Barroso, W. K. S., Chinem, B., Jardim, L., ... & Jardim, P. C. B. V. (2015). The natural history of cardiovascular risk factors in health professionals: 20-year follow-up. BMC public health15(1), 1.

Jerrett, M., Arain, A., Kanaroglou, P., Beckerman, B., Potoglou, D., Sahsuvaroglu, T., ... & Giovis, C. (2005). A review and evaluation of intraurban air pollution exposure models. Journal of Exposure Science and Environmental Epidemiology15(2), 185-204.

Kiechl, S., Willeit, J., & Bruneck Study Group. (1999). The natural course of atherosclerosis Part I: incidence and progression. Arteriosclerosis, thrombosis, and vascular biology19(6), 1484-1490.

Kounadi, Ourania, and Michael Leitner. "Adaptive areal elimination (AAE): A transparent way of disclosing protected spatial datasets." Computers, Environment and Urban Systems 57 (2016): 59-67.

Krewski D, Jerrett M, Burnett RT, Ma R, Hughes E, Shi Y, Turner MC, Pope CA III, Thurston G, Calle EE, Thun MJ. 2009. Extended Follow-Up and Spatial Analysis of the American Cancer Society Study Linking Particulate Air Pollution and Mortality. HEI Research Report 140. Health Effects Institute, Boston, MA

Krewski, D., Burnett, R.T., Goldberg, M.S., Hoover, K., Siemiatycki, J, Jerrett, M., Abrahamowicz, M. and White, W.H. (2000). Reanalysis of the Harvard Six Cities Study and the American Cancer Society Study of Particulate Air Pollution and Mortality. A Special Report of the Health Effect Institute’s Particle Epidemiology Reanalysis Project.

Ma, R., Hughes, E., Shi, Y., Turnter,  M.C., Poep, A.C. III, Thurston, G., Calle, E.E., and Thun, M.J.

Krishnan, R. M., Adar, S. D., Szpiro, A. A., Jorgensen, N. W., Van Hee, V. C., Barr, R. G., ... & Kaufman, J. D. (2012). Vascular responses to long-and short-term exposure to fine particulate matter: MESA Air (Multi-Ethnic Study of Atherosclerosis and Air Pollution). Journal of the American College of Cardiology60(21), 2158-2166.

Künzli, N., Jerrett, M., Mack, W. J., Beckerman, B., LaBree, L., Gilliland, F., ... & Hodis, H. N. (2005). Ambient air pollution and atherosclerosis in Los Angeles. Environmental health perspectives, 201-206.

Künzli, N., Perez, L., von Klot, S., Baldassarre, D., Bauer, M., Basagana, X., ... & Fuks, K. (2011). Investigating air pollution and atherosclerosis in humans: concepts and outlook. Progress in cardiovascular diseases53(5), 334-343.

Mills, N. L., Donaldson, K., Hadoke, P. W., Boon, N. A., MacNee, W., Cassee, F. R., ... & Newby, D. E. (2009). Adverse cardiovascular effects of air pollution. Nature clinical practice Cardiovascular medicine6(1), 36-44.

Mustafić, H., Jabre, P., Caussin, C., Murad, M. H., Escolano, S., Tafflet, M., ... & Jouven, X. (2012). Main air pollutants and myocardial infarction: a systematic review and meta-analysis. Jama307(7), 713-721.

Nasari, M. M., Szyszkowicz, M., Chen, H., Crouse, D., Turner, M.C., Michael, J. Pope, C.A. III, Hubbell B., Fann, N., Cohen, A., Gapstur, S.M., Diver, W.R., Stieb, D., Forouzanfar, M. H., Kim, S.-Y., Olives, C. Krewski, D., Burnett, R.T (2016). A class of non-linear exposure-response models suitable for health impact assessment applicable to large cohort studies of ambient air pollution.  Air Quality, Atmosphere, and Health. DOI 10.1007/s11869-016-0398-z

Newby, D. E., Mannucci, P. M., Tell, G. S., Baccarelli, A. A., Brook, R. D., Donaldson, K., ... & Hoek, G. (2014). Expert position paper on air pollution and cardiovascular disease. European heart journal, ehu458.

Oakes, M., Baxter, L., & Long, T. C. (2014). Evaluating the application of multipollutant exposure metrics in air pollution health studies. Environment international69, 90-99.

Özkaynak, H., Baxter, L. K., Dionisio, K. L., & Burke, J. (2013). Air pollution exposure prediction approaches used in air pollution epidemiology studies. Journal of Exposure Science and Environmental Epidemiology23(6), 566-572.

Pope III, C. A., & Dockery, D. W. (2006). Health effects of fine particulate air pollution: lines that connect. Journal of the air & waste management association56(6), 709-742.

Pope III, C. A., Cropper, M., Coggins, J., & Cohen, A. (2015). Health benefits of air pollution abatement policy: Role of the shape of the concentration–response function. Journal of the Air & Waste Management Association65(5), 516-522.

Pope, C. A., Burnett, R. T., Krewski, D., Jerrett, M., Shi, Y., Calle, E. E., & Thun, M. J. (2009). Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke shape of the exposure-response relationship. Circulation120(11), 941-948.

Rodgers, Sarah E., et al. "Protecting health data privacy while using residence-based environment and demographic data." Health & place 18.2 (2012): 209-217.

Rothstein, Mark A. "Is deidentification sufficient to protect health privacy in research?." The American Journal of Bioethics 10.9 (2010): 3-11.

Schwartz, J. (2000). Harvesting and long term exposure effects in the relation between air pollution and mortality. American journal of epidemiology151(5), 440-448.

Schwartz, Joel, and Antonella Zanobetti. "Using meta-smoothing to estimate dose-response trends across multiple studies, with application to air pollution and daily death." Epidemiology 11.6 (2000): 666-672.

Shah, A. S., Langrish, J. P., Nair, H., McAllister, D. A., Hunter, A. L., Donaldson, K., ... & Mills, N. L. (2013). Global association of air pollution and heart failure: a systematic review and meta-analysis. The Lancet,382(9897), 1039-1048.

Sheppard, L., Burnett, R. T., Szpiro, A. A., Kim, S. Y., Jerrett, M., Pope III, C. A., & Brunekreef, B. (2012). Confounding and exposure measurement error in air pollution epidemiology. Air Quality, Atmosphere & Health5(2), 203-216.

Shin, H. H., Cohen, A. J., Pope, C. A., Ezzati, M., Lim, S. S., Hubbell, B. J., & Burnett, R. T. (2015). Meta‐Analysis Methods to Estimate the Shape and Uncertainty in the Association Between Long‐Term Exposure to Ambient Fine Particulate Matter and Cause‐Specific Mortality Over the Global Concentration Range. Risk Analysis.

Sun, Q., Hong, X., & Wold, L. E. (2010). Cardiovascular effects of ambient particulate air pollution exposure. Circulation121(25), 2755-2765.

Sun, Q., Wang, A., Jin, X., Natanzon, A., Duquaine, D., Brook, R. D., ... & Chen, L. C. (2005). Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. Jama,294(23), 3003-3010.

Szpiro, A. A., Sampson, P. D., Sheppard, L., Lumley, T., Adar, S. D., & Kaufman, J. D. (2010). Predicting intra‐urban variation in air pollution concentrations with complex spatio‐temporal dependencies. Environmetrics,21(6), 606-631.

U.S. EPA. 2009 Final Report: Integrated Science Assessment for Particulate Matter. U.S. Environmental Protection Agency, Washington, DC, EPA/600/R-08/139F, 2009.

Vayena, Effy, et al. "Ethical challenges of big data in public health." PLoS Comput Biol 11.2 (2015): e1003904.

Wartenberg, Daniel, and W. Douglas Thompson. "Privacy versus public health: the impact of current confidentiality rules." American Journal of Public Health 100.3 (2010): 407-412.

Zanobetti, Antonella, Andrea Baccarelli, and Joel Schwartz. "Gene–Air Pollution Interaction and Cardiovascular Disease: A Review." Progress in cardiovascular diseases 53.5 (2011): 344-352.

Zanobetti, A., Austin, E., Coull, B. A., Schwartz, J., & Koutrakis, P. (2014). Health effects of multi-pollutant profiles. Environment international71, 13-19.

Zanobetti, A., Schwartz, J., Samoli, E., Gryparis, A., Touloumi, G., Peacock, J., ... & Goren, A. (2003). The temporal pattern of respiratory and heart disease mortality in response to air pollution. Environmental health perspectives111(9), 1188.

Zeger, S. L., Thomas, D., Dominici, F., Samet, J. M., Schwartz, J., Dockery, D., & Cohen, A. (2000). Exposure measurement error in time-series studies of air pollution: concepts and consequences. Environmental health perspectives108(5), 419.

F. Special Requirements
Agency policy and ethical considerations prevent EPA technical staff and managers from providing applicants with information that may create an unfair competitive advantage.  Consequently, EPA employees will not review, comment, advise, and/or provide technical assistance to applicants preparing applications in response to EPA RFAs.  EPA employees cannot endorse any particular application.

Multiple Investigator applications may be submitted as: (1) a single Lead Principal Investigator (PI) application with Co-PI(s) or (2) a Multiple PI application (with a single Contact PI).  If you choose to submit a Multiple PI application, you must follow the specific instructions provided in Sections IV. and V. of this RFA.  For further information, please see the EPA Implementation Plan for Policy on Multiple Principal Investigators (RBM Toolkit).

This solicitation provides the opportunity for the submission of applications for projects that may involve human subjects research.  There are many scientific and ethical considerations that must be addressed in such studies by the study sponsor and research team, including, but not limited to, those related to recruitment, retention, participant compensation, third-party issues, researcher-participant interactions, researcher-community interactions, communications, interventions, and education.  All such research must comply with the requirements of 40 CFR Part 26, and any human observational exposure studies must also adhere to the principles set forth in the Scientific and Ethical Approaches for Observational Exposure Studies (SEAOES) (PDF) (132 pp, 1.79 MB) (EPA/600/R-08/062) document.  SEAOES, which was published by researchers in EPA and which discusses the principles for the ethical conduct of human research studies, serves as a resource for applicants interested in applying under this solicitation.  References to “SEAOES Principles” in this solicitation refers, in general, to the issues of interest in conducting human subjects research studies that maintain the highest scientific and ethical standards and safety during the conduct of these studies.  All applications must include a Human Subjects Research Statement (HSRS; described in Section IV.C.5.c of this solicitation) and if the project involves human subjects research, it will be subject to an additional level of review prior to funding decisions being made as described in Sections V.C and V.D of this solicitation.

Groups of two or more eligible applicants may choose to form a consortium and submit a single application for this assistance agreement.  The application must identify which organization will be the recipient of the assistance agreement and which organizations(s) will be subawardees of the recipient.

The application should include a plan (see “Data Plan” in section IV.C.5.d) to make available to the NCER project officer all data generated (produced under the award) from observations, analyses, or model development used under an agreement awarded from this RFA.  The data must be available in a format and with documentation such that they may be used by others in the scientific community.

These awards may involve the collection of “Geospatial Information,” which includes information that identifies the geographic location and characteristics of natural or constructed features or boundaries on the Earth or applications, tools, and hardware associated with the generation, maintenance, or distribution of such information.  This information may be derived from, among other things, a Geographic Positioning System (GPS), remote sensing, mapping, charting, and surveying technologies, or statistical data. 

II. AWARD INFORMATION

It is anticipated that a total of approximately $3 million will be awarded under this announcement, depending on the availability of funds, quality of applications received, and other applicable considerations.  The EPA anticipates funding one (1) award under this RFA.  Requests for amounts in excess of a total of $3,000,000, including direct and indirect costs, will not be considered.  The total project period requested in an application submitted for this RFA may not exceed 5 years. 

The EPA reserves the right to reject all applications and make no awards, or make fewer awards than anticipated, under this RFA.  The EPA reserves the right to make additional awards under this announcement, consistent with Agency policy, if additional funding becomes available after the original selections are made.  Any additional selections for awards will be made no later than six months after the original selection decisions.

In appropriate circumstances, EPA reserves the right to partially fund proposals/applications by funding discrete portions or phases of proposed projects. If EPA decides to partially fund a proposal/application, it will do so in a manner that does not prejudice any applicants or affect the basis upon which the proposal/application, or portion thereof, was evaluated and selected for award, and therefore maintains the integrity of the competition and selection process.

EPA intends to award only grants under this announcement. Under a grant, EPA scientists and engineers are not permitted to be substantially involved in the execution of the research.  However, EPA encourages interaction between its own laboratory scientists and grant Principal Investigators after the award of an EPA grant for the sole purpose of exchanging information in research areas of common interest that may add value to their respective research activities.  This interaction must be incidental to achieving the goals of the research under a grant.  Interaction that is “incidental” does not involve resource commitments.

III. ELIGIBILITY INFORMATION

A. Eligible Applicants
Public nonprofit institutions/organizations (includes public nonprofit institutions of higher education and hospitals) and private nonprofit institutions/organizations (includes private nonprofit institutions of higher education and hospitals) located in the U.S., state and local governments, Federally Recognized Indian Tribal Governments, and U.S. territories or possessions are eligible to apply.  Profit-making firms are not eligible to receive assistance agreements from the EPA under this program.

Eligible nonprofit organizations include any organizations that:
1) Are operated primarily for scientific, educational, service, charitable, or similar purposes in the public interest; 2) Are not organized primarily for profit; and 3) Use its net proceeds to maintain, improve, and/or expand its operations. However, nonprofit organizations described in Section 501(c) (4) of the Internal Revenue Code that lobby are not eligible to apply.

Foreign governments, international organizations, and non-governmental international organizations/institutions are not eligible to apply.

National laboratories funded by Federal Agencies (Federally-Funded Research and Development Centers, “FFRDCs”) may not apply.  FFRDC employees may cooperate or collaborate with eligible applicants within the limits imposed by applicable legislation and regulations.  They may participate in planning, conducting, and analyzing the research directed by the applicant, but may not direct projects on behalf of the applicant organization.  The institution, organization, or governance receiving the award may provide funds through its assistance agreement from the EPA to an FFRDC for research personnel, supplies, equipment, and other expenses directly related to the research.  However, salaries for permanent FFRDC employees may not be provided through this mechanism.

Federal Agencies may not apply.  Federal employees are not eligible to serve in a principal leadership role on an assistance agreement, and may not receive salaries or augment their Agency’s appropriations in other ways through awards made under this program.

The applicant institution may enter into an agreement with a Federal Agency to purchase or utilize unique supplies or services unavailable in the private sector to the extent authorized by law.  Examples are purchase of satellite data, chemical reference standards, analyses, or use of instrumentation or other facilities not available elsewhere.  A written justification for federal involvement must be included in the application.  In addition, an appropriate form of assurance that documents the commitment, such as a letter of intent from the Federal Agency involved, should be included.

Potential applicants who are uncertain of their eligibility should contact Ron Josephson (josephson.ron@epa.gov) in NCER, phone: 202-564-7823.

B. Cost sharing
Institutional cost-sharing is not required.

C. Other
Applications must substantially comply with the application submission instructions and requirements set forth in Section IV of this announcement or they will be rejected.  In addition, where a page limitation is expressed in Section IV with respect to parts of the application, pages in excess of the page limit will not be reviewed.  In addition, applications must be submitted through Grants.gov as stated in Section IV of this announcement (except in the limited circumstances where another mode of submission is specifically allowed for as explained in Section IV) on or before the application submission deadline published in Section IV of this announcement. Applicants are responsible for following the submission instructions in Section IV of this announcement (see Section IV.F. “Submission Instructions and Other Submission Requirements” for further information) to ensure that their application is timely submitted. Applications submitted after the submission deadline will be considered late and deemed ineligible without further consideration unless the applicant can clearly demonstrate that it was late due to EPA mishandling or because of technical problems associated with Grants.gov or relevant SAM.gov system issues. An applicant’s failure to timely submit their application through Grants.gov because they did not timely or properly register in SAM.gov or Grants.gov will not be considered an acceptable reason to consider a late submission. Applicants should confirm receipt of their application with the Electronic Submissions Contact shown in this solicitation as soon as possible after the submission deadline—failure to do so may result in your application not being reviewed.

Also, applications exceeding the funding limits or project period term described herein will be rejected without review.  Further, applications that fail to demonstrate a public purpose of support or stimulation (e.g., by proposing research which primarily benefits a Federal program or provides a service for a Federal agency) will not be funded. 

Applications deemed ineligible for funding consideration will be notified within fifteen calendar days of the ineligibility determination.

IV. APPLICATION AND SUBMISSION INFORMATION

Additional provisions that apply to this solicitation and/or awards made under this solicitation, including but not limited to those related to confidential business information, contracts and subawards under grants, and proposal assistance and communications, can be found at EPA Solicitation Clauses.

These, and the other provisions that can be found at the website link, are important, and applicants must review them when preparing applications for this solicitation.   If you are unable to access these provisions electronically at the website above, please communicate with the EPA contact listed in this solicitation to obtain the provisions.

Formal instructions for submission through Grants.gov are in Section F.

A. Grants.gov Submittal Requirements and Limited Exception Procedures
Applicants, except as noted below, must apply electronically through Grants.gov under this funding opportunity based on the Grants.gov instructions in this announcement. If an applicant does not have the technical capability to apply electronically through Grants.gov because of limited or no internet access which prevents them from being able to upload the required application materials to Grants.gov, the applicant must contact OGDWaivers@epa.gov or the address listed below in writing (e.g., by hard copy, email) at least 15 calendar days prior to the submission deadline under this announcement to request approval to submit their application materials through an alternate method.

Mailing Address:
OGD Waivers
c/o Barbara Perkins
USEPA Headquarters
William Jefferson Clinton Building
1200 Pennsylvania Ave., N. W.
Mail Code: 3903R
Washington, DC 20460

Courier Address:
OGD Waivers
c/o Barbara Perkins
Ronald Reagan Building
1300 Pennsylvania Ave., N.W.
Rm # 51267
Washington, DC 20004

In the request, the applicant must include the following information:
Funding Opportunity Number (FON)
Organization Name and DUNS
Organization’s Contact Information (email address and phone number)
Explanation of how they lack the technical capability to apply electronically through Grants.gov because of: 1) limited internet access or 2) no internet access which prevents them from being able to upload the required application materials through Grants.gov.

EPA will only consider alternate submission exception requests based on the two reasons stated above and will timely respond to the request -- all other requests will be denied. If an alternate submission method is approved, the applicant will receive documentation of this approval and further instructions on how to apply under this announcement. Applicants will be required to submit the documentation of approval with any initial application submitted under the alternative method. In addition, any submittal through an alternative method must comply with all applicable requirements and deadlines in the announcement including the submission deadline and requirements regarding proposal content and page limits (although the documentation of approval of an alternate submission method will not count against any page limits).

If an exception is granted, it is valid for submissions to EPA for the remainder of the entire calendar year in which the exception was approved and can be used to justify alternative submission methods for application submissions made through December 31 of the calendar year in which the exception was approved (e.g., if the exception was approved on March 1, 2015, it is valid for any competitive or non-competitive application submission to EPA through December 31, 2015). Applicants need only request an exception once in a calendar year and all exceptions will expire on December 31 of that calendar year. Applicants must request a new exception from required electronic submission through Grants.gov for submissions for any succeeding calendar year. For example, if there is a competitive opportunity issued on December 1, 2015 with a submission deadline of January 15, 2016, the applicant would need a new exception to submit through alternative methods beginning January 1, 2016.

Please note that the process described in this section is only for requesting alternate submission methods. All other inquiries about this announcement must be directed to the Agency Contact listed in Section VII of the announcement. Queries or requests submitted to the email address identified above for any reason other than to request an alternate submission method will not be acknowledged or answered.

B. Application Package Information
Use the application package available at Grants.gov (see Section IV.F. “Submission Instructions and Other Submission Requirements”).  Note: With the exception of the current and pending support form (available at How to Apply and Required Forms), all necessary forms are included in the electronic application package. Make sure to include the current and pending support form in your Grants.gov submission.

An email will be sent by NCER to the Lead/Contact PI and the Administrative Contact (see below) to acknowledge receipt of the application and transmit other important information.  The email will be sent from receipt.application@epa.gov; emails to this address will not be accepted.  If you do not receive an email acknowledgement within 10 calendar days of the submission closing date, immediately inform the Electronic Submissions Contact shown in this solicitation.  Failure to do so may result in your application not being reviewed. See Section IV.F. “Submission Instructions and Other Submission Requirements” for additional information regarding the application receipt acknowledgment.

C. Content and Form of Application Submission
The application is made by submitting the materials described below.  Applications must contain all information requested and be submitted in the formats described.  

  1. Standard Form 424

    The applicant must complete Standard Form 424.  Instructions for completion of the SF424 are included with the form.  (However, note that EPA requires that the entire requested dollar amount appear on the SF424, not simply the proposed first year expenses.)  The form must contain the signature of an authorized representative of the applying organization. 

    Applicants are required to provide a unique entity identifier (formerly ‘DUNS number’) when applying for federal grants or cooperative agreements.  Organizations may receive a unique entity identifier, at no cost, by calling the dedicated toll-free request line at 1-866-705-5711, or visiting the website at: Dun & Bradstreet.

    Executive Order 12372, “Intergovernmental Review of Federal Programs,” does not apply to the Office of Research and Development's research and training programs unless EPA has determined that the activities that will be carried out under the applicants' proposal (a) require an Environmental Impact Statement (EIS), or (b) do not require an EIS but will be newly initiated at a particular site and require unusual measures to limit the possibility of adverse exposure or hazard to the general public, or (c) have a unique geographic focus and are directly relevant to the governmental responsibilities of a State or local government within that geographic area.

    If EPA determines that Executive Order 12372 applies to an applicant's proposal, the applicant must follow the procedures in 40 CFR Part 29.  The applicant must notify their state's single point of contact (SPOC). To determine whether their state participates in this process, and how to comply, applicants should consult Intergovernmental Review (SPOC List) .  If an applicant is in a State that does not have a SPOC, or the State has not selected research and development grants for intergovernmental review, the applicant must notify directly affected State, area wide, regional and local entities of its proposal.

    EPA will notify the successful applicant(s) if Executive Order 12372 applies to its proposal prior to award.

  2. Key Contacts

    The applicant must complete the “Key Contacts” form found in the Grants.gov application package.  An “Additional Key Contacts” form is also available at How to Apply and Required Forms. The Key Contacts form should also be completed for major sub-agreements (i.e., primary investigators).  Do not include information for consultants or other contractors.  Please make certain that all contact information is accurate.

    For Multiple PI applications:  The Additional Key Contacts form must be completed (see Section I.F. for further information).  Note: The Contact PI must be affiliated with the institution submitting the application.  EPA will direct all communications related to scientific, technical, and budgetary aspects of the project to the Contact PI; however, any information regarding an application will be shared with any PI upon request.  The Contact PI is to be listed on the Key Contact Form as the Project Manager/Principal Investigator (the term Project Manager is used on the Grants.gov form, the term Principal Investigator is used on the form located on How to Apply and Required Forms). For additional PIs, complete the Major Co-Investigator fields and identify PI status next to the name (e.g., “Name: John Smith, Principal Investigator”). 

  3. Table of Contents

    Provide a list of the major subdivisions of the application indicating the page number on which each section begins.

  4. Abstract (1 page)

    The abstract is a very important document in the review process.  Therefore, it is critical that the abstract accurately describes the research being proposed and conveys all the essential elements of the research.  Also, the abstracts of applications that receive funding will be posted on EPA’s Research Grants website.

    The abstract should include the information described below (a-h).  Examples of abstracts for current grants may be found on EPA’s Research Grants website.

    1. Funding Opportunity Title and Number for this proposal.
    2. Project Title: Use the exact title of your project as it appears in the application.  The title must be brief yet represent the major thrust of the project.  Because the title will be used by those not familiar with the project, use more commonly understood terminology.  Do not use general phrases such as “research on.”
    3. Investigators: For applications with multiple investigators, state whether this is a single Lead PI (with co-PIs) or Multiple PI application (see Section I.F.).  For Lead PI applications, list the Lead PI, then the name(s) of each co-PI who will significantly contribute to the project.  For Multiple PI applications, list the Contact PI, then the name(s) of each additional PI.  Provide a website URL or an email contact address for additional information.
    4. Institution(s): In the same order as the list of investigators, list the name, city and state of each participating university or other applicant institution.  The institution applying for assistance must be clearly identified.
    5. Project Period and Location: Show the proposed project beginning and ending dates and the performance site(s)/geographical location(s) where the work will be conducted.
    6. Project Cost: Show the total funding requested from the EPA (include direct and indirect costs for all years).
    7. Project Summary: Provide three subsections addressing: (1) the objectives of the study (including any hypotheses that will be tested), (2) the experimental approach to be used (a description of the proposed project), and (3) the expected results (outputs/outcomes) of the project and how it addresses the research needs identified in the solicitation, including the estimated improvement in risk assessment or risk management that will result from successful completion of the proposed work.
    8. Supplemental Keywords: Without duplicating terms already used in the text of the abstract, list keywords to assist database searchers in finding your research.  A list of suggested keywords may be found at: How to Apply and Required Forms.

  5. Research Plan, Quality Assurance Statement, Human Subjects Research Statement, Data Plan, and References

    1. Research Plan (15 pages)

      Applications should focus on a limited number of research objectives that adequately and clearly demonstrate that they meet the RFA requirements. Explicitly state the main hypotheses that you will investigate, the data you will create or use, the analytical tools you will use to investigate these hypotheses or analyze these data, and the results you expect to achieve. Research methods must be clearly stated so that reviewers can evaluate the appropriateness of your approach and the tools you intend to use. A statement such as: “we will evaluate the data using the usual statistical methods” is not specific enough for peer reviewers.

      This description must not exceed fifteen (15) consecutively numbered (bottom center), 8.5x11-inch pages of single-spaced, standard 12-point type with 1-inch margins. While these guidelines establish the minimum type size requirements, applicants are advised that readability is of paramount importance and should take precedence in selection of an appropriate font for use in the proposal.

      The description must provide the following information:

      1. Objectives: List the objectives of the proposed research and the hypotheses being tested during the project, and briefly state why the intended research is important and how it fulfills the requirements of the solicitation. This section should also include any background or introductory information that would help explain the objectives of the study. If this application is to expand upon research supported by an existing or former assistance agreement awarded under the STAR program, indicate the number of the agreement and provide a brief report of progress and results achieved under it.
      2. Approach/Activities: Outline the research design, methods, and techniques that you intend to use in meeting the objectives stated above.
      3. Innovation: Describe how your project shifts current research or engineering paradigms by using innovative theoretical concepts, approaches or methodologies, instrumentation or interventions applicable to one or more fields of research.
      4. Expected Results, Benefits, Outputs, and Outcomes: Describe the expected outputs and outcomes resulting from the project. This section should also discuss how the research results will lead to solutions to environmental problems and improve the public’s ability to protect the environment and human health. A clear, concise description will help NCER and peer reviewers understand the merits of the research.
      5. Project Management: Discuss other information relevant to the potential success of the project. This should include facilities, personnel expertise/experience, project schedules with associated milestones and target dates, proposed management, interactions with other institutions, etc. Describe the approach, procedures, and controls for ensuring that awarded grant funds will be expended in a timely and efficient manner and detail how project objectives will be successfully achieved within the grant period. Describe how progress toward achieving the expected results (outputs and outcomes) of the research will be tracked and measured. Applications for multi-investigator projects must identify project management and the functions of each investigator in each team and describe plans to communicate and share data.
      6. Appendices may be included but must remain within the 15-page limit.

    2. Quality Assurance Statement (3 pages)

      For projects involving environmental data collection or processing, conducting surveys, modeling, method development, or the development of environmental technology (whether hardware-based or via new techniques), provide a Quality Assurance Statement (QAS) regarding the plans for processes that will be used to ensure that the products of the research satisfy the intended project objectives. Follow the guidelines provided below to ensure that the QAS describes a system that complies with ANSI/ASQC E4, Specifications and Guidelines for Quality Systems for Environmental Data Collection and Environmental Technology Programs. Do not exceed three consecutively numbered, 8.5x11-inch pages of single-spaced, standard 12-point type with 1-inch margins.

      NOTE: If selected for award, applicants will be expected to provide additional quality assurance documentation.

      Address each applicable section below by including the required information, referencing the specific location of the information in the Research Plan, or explaining why the section does not apply to the proposed research. (Not all will apply.)

      1. Identify the individual who will be responsible for the quality assurance (QA) and quality control (QC) aspects of the research along with a brief description of this person’s functions, experience, and authority within the research organization. Describe the organization’s general approach for conducting quality research. (QA is a system of management activities to ensure that a process or item is of the type and quality needed for the project. QC is a system of activities that measures the attributes and performance of a process or item against the standards defined in the project documentation to verify that they meet those stated requirements.)

      2. Discuss project objectives, including quality objectives, any hypotheses to be tested, and the quantitative and/or qualitative procedures that will be used to evaluate the success of the project. Include any plans for peer or other reviews of the study design or analytical methods.

      3. Address each of the following project elements as applicable:
        1. Collection of new/primary data:
          (Note: In this case the word “sample” is intended to mean any finite part of a statistical population whose properties are studied to gain information about the whole. If certain attributes listed below do not apply to the type of samples to be used in your research, simply explain why those attributes are not applicable.)
          1. Discuss the plan for sample collection and analysis. As applicable, include sample type(s), frequency, locations, sample sizes, sampling procedures, and the criteria for determining acceptable data quality (e.g., precision, accuracy, representativeness, completeness, comparability, or data quality objectives).
          2. Describe the procedures for the handling and custody of samples including sample collection, identification, preservation, transportation, and storage, and how the accuracy of test measurements will be verified.
          3. Describe or reference each analytical method to be used, any QA or QC checks or procedures with the associated acceptance criteria, and any procedures that will be used in the calibration and performance evaluation of the analytical instrumentation.
          4. Discuss the procedures for overall data reduction, analysis, and reporting. Include a description of all statistical methods to make inferences and conclusions, acceptable error rates and/or power, and any statistical software to be used.

        2. Use of existing/secondary data (i.e., data previously collected for other purposes or from other sources):
          1. Identify the types of secondary data needed to satisfy the project objectives. Specify requirements relating to the type of data, the age of data, geographical representation, temporal representation, and technological representation, as applicable.
          2. Specify the source(s) of the secondary data and discuss the rationale for selection.
          3. Establish a plan to identify the sources of the secondary data in all deliverables/products.
          4. Specify quality requirements and discuss the appropriateness for their intended use. Accuracy, precision, representativeness, completeness, and comparability need to be addressed, if applicable.
          5. Describe the procedures for determining the quality of the secondary data.
          6. Describe the plan for data management/integrity.

        3. Method development:
          (Note: The data collected for use in method development or evaluation should be described in the QAS as per the guidance in section 3A and/or 3B above.)

          Describe the scope and application of the method, any tests (and measurements) to be conducted to support the method development, the type of instrumentation that will be used and any required instrument conditions (e.g., calibration frequency), planned QC checks and associated criteria (e.g., spikes, replicates, blanks), and tests to verify the method’s performance.

        4. Development or refinement of models:
          (Note: The data collected for use in the development or refinement of models should be described in the QAS as per the guidance in section 3A and/or 3B above.)
          1. Discuss the scope and purpose of the model, key assumptions to be made during development/refinement, requirements for code development, and how the model will be documented.
          2. Discuss verification techniques to ensure the source code implements the model correctly.
          3. Discuss validation techniques to determine that the model (assumptions and algorithms) captures the essential phenomena with adequate fidelity.
          4. Discuss plans for long-term maintenance of the model and associated data.

        5. Development or operation of environmental technology:
          (Note: The data collected for use in the development or evaluation of the technology should be described in the QAS as per the guidance in section 3A and/or 3B above.)
          1. Describe the overall purpose and anticipated impact of the technology.
          2. Describe the technical and quality specifications of each technology component or process that is to be designed, fabricated, constructed, and/or operated.
          3. Discuss the procedure to be used for documenting and controlling design changes.
          4. Discuss the procedure to be used for documenting the acceptability of processes and components, and discuss how the technology will be benchmarked and its effectiveness determined.
          5. Discuss the documentation requirements for operating instructions/guides for maintenance and use of the system(s) and/or process(s).

        6. Conducting surveys:
          (Note: The data to be collected in the survey and any supporting data should be described in the QAS as per the guidance in section 3A and/or 3B above.)

          Discuss the justification for the size of the proposed sample for both the overall project and all subsamples for specific treatments or tests. Identify and explain the rational for the proposed statistical techniques (e.g., evaluation of statistical power).


      4. Discuss data management activities (e.g., record-keeping procedures, data-handling procedures, and the approach used for data storage and retrieval on electronic media). Include any required computer hardware and software and address any specific performance requirements for the hardware/software configuration used.

    3. EPA Human Subjects Research Statement (HSRS) (4 pages)

      Human subjects research supported by the EPA is governed by EPA Regulation 40 CFR Part 26 (Protection of Human Subjects). This includes the Common Rule at subpart A and prohibitions and additional protections for pregnant women and fetuses, nursing women, and children at subparts B, C, and D. While retaining the same notation, subparts B, C, and D are substantively different in 40 CFR 26 than in the more commonly cited 45 CFR 46. Particularly noteworthy is that research meeting the regulatory definition of intentional exposure research found in subpart B is prohibited by that subpart in pregnant women, nursing women, and children. EPA Policy Order 1000.17 Change A1 further clarifies this definition to include any intervention that manipulates their environment (i.e. modifies subjects’ exposure). Research meeting the regulatory definition of observational research (any research that is not intentional exposure research) found in subparts C and D is subject to the additional protections found in those subparts for pregnant women and fetuses (subpart C) and children (subpart D). These subparts also differ markedly from the language in 45 CFR 46. For more information, please see: Basic Information about Human Subjects Research.

      Procedures for the review and oversight of human research subject to 40 CFR Part 26 are also provided in EPA Order 1000.17 Change A1. These include review of projects for EPA-supported human research by the EPA Human Subjects Research Review Official (HSRRO). EPA Order 1000.17 Change A1 requires preliminary approval by the HSRRO of all proposed EPA-supported human research before the agreement can be entered into. Additional requirements must be met and final approval received from the HSRRO before the research can begin. When reviewing human observational exposure studies, EPA Order 1000.17 Change A1 requires the HSRRO to apply the principles described in the SEAOES (PDF) (132 pp, 1.79 MB) document and grant approval only to studies that adhere to those principles.

      All applications submitted under this solicitation must include a HSRS as described below. Please use the definitions below to determine whether the proposed research involves human subjects, and then prepare a HSRS as explained below in the “HSRS Requirements” section.

      Definitions (from 40 CFR Part 26 Subparts A, B, and C) to determine the involvement of human subjects in proposed research:

      • "Human subject" means a living individual about whom an investigator (whether professional or student) conducting research obtains (1) data through intervention or interaction with the individual, or (2) identifiable private information.
      • "Intervention" includes both physical procedures by which data are gathered and manipulations of the subject or the subject's environment that are performed for research purposes.
      • "Interaction" includes communication or interpersonal contact between investigator and subject.
      • "Private information" includes information about behavior that occurs in a context in which an individual can reasonably expect that no observation or recording is taking place, and information which has been provided for specific purposes by an individual and which the individual can reasonably expect will not be made public (for example, a medical record).
      • "Individually identifiable" means the identity of the subject is or may readily be ascertained by the investigator or associated with the information.
      • "Research involving the intentional exposure of a human subject" means a study of a substance in which the exposure to the substance experienced by a human subject participating in the study would not have occurred but for the human subject’s participation in the study. In addition, EPA Policy 1000.17 Change A1 requires the HSRRO to conceptualize intentional exposure research quite broadly:

        (l) Research that includes the gathering of physiological measurements (e.g., monitoring a subject's cardio respiratory performance) or the collection of body fluids, tissue or expired air from subjects; or (2) Research that requires subjects to perform specific tasks other than their normal activities or manipulates their environment (e.g., modifies their exposure); or (3) Research that gathers or records private information (as defined in 40 CFR 26.102 (f)(2)) in a manner that associates such information with an identifiable subject.

      • "Observational research" means any human research that does not meet the definition of research involving intentional exposure of a human subject. Please note that surveys, interviews, and focus groups with individuals may constitute human subjects research. Additional information is available at: Basic Information about Human Subjects Research
       

      Human Subjects Research Statement (HSRS) Requirements
      If the proposed research does not involve human subjects as defined above, provide the following statement in your application package as your HSRS: “The proposed research does not involve human subjects.” Applicants should provide a clear justification about how the proposed research does not meet the definition (for example, all samples come from deceased individuals OR samples are purchased from a commercial source and provided without identifiers, etc.).

      If the proposed research does involve human subjects, then include in your application package a HSRS that addresses each applicable section listed below, referencing the specific location of the information in the Research Plan, providing the information in the HSRS, or explaining why the section does not apply to the proposed research. (Not all will apply.) Please use the definitions provided above to ensure consistency in the interpretation of terminology. Do not exceed four consecutively numbered, 8.5x11-inch pages of single-spaced, standard 12-point type with 1-inch margins.

      NOTE: Before EPA approves any research involving human subjects, the requirements of the regulations at 40 CFR Part 26 must be met. Also, before EPA approves human observational exposure research, EPA will examine it to ensure consistency with the SEAOES Principles. The federal Office for Human Research Protections requires that federally funded human subjects research only be conducted at facilities covered by a Federalwide Assurance (FWA). An FWA is a document that designates the Institutional Review Board that will review and oversee the research, specifies the ethical principles under which the research will be conducted, and names the individuals who will be responsible for the proper conduct of the research. The factors below are not intended to be exhaustive of all those needed for the HSRRO to provide the final approval necessary for research to be conducted, but provide a basis upon which the HSRRO may grant the conditional approval necessary for the funding process to begin.

      Items 1 – 9 must be completed for all studies involving human subjects. For studies involving intentional exposures (i.e. increases, decreases, or otherwise modifies subjects’ exposure), also complete Items 10 -14.

      1. Human Subjects involvement, characteristics, and design: Describe the proposed involvement of human subjects in the work being proposed.
      2. Benefits of research/value to society: Discuss the potential benefits of the research to the research participants and others, including the value of the knowledge to be gained by the research.
      3. Potential risks to subjects: Describe the potential risks to human subjects (e.g., physical, psychological, financial, legal, or other) and assess their likelihood and seriousness to the human subjects.
      4. Protection against risks: Describe planned procedures for protecting against or minimizing potential risks and assess their likely effectiveness.
      5. Protection of privacy and confidentiality: Describe how data, specimens, and/or records will be collected, managed, and protected, including at collaborating sites, if any, as well as at the primary site.
      6. Protection of vulnerable groups: Explain the rationale for inclusion of vulnerable populations and describe the additional protections in place, if any, for protecting vulnerable populations in the research.
      7. Risk/benefit relationship: Justify how the risks are reasonable in relation to expected benefits.
      8. Informed Consent Process: Describe planned procedures for the process of obtaining and maintaining informed consent. Include a description of the circumstances under which consent will be sought and obtained, who will seek it, the nature of the information to be provided to prospective subjects, and the method of documenting consent.
      9. Relationship between researcher and community: If the research will take place in a community setting, describe the procedures in place for defining the community, obtaining its involvement in the research, and establishing and maintaining trust.
       

      Items 10-14: Projects involving the intentional exposure (i.e. increases, decreases, or otherwise modifies subjects’ exposure) of human subjects require additional justification. Note that intentional exposure of children, pregnant women or nursing women is prohibited, according to 40 CFR Part 26, subpart B. Please refer to the definition of “intentional exposure” described earlier in this section.

      Please also note that projects involving intentional exposure of human subjects should only be considered if they have the potential of providing a clear health or environmental benefit or if acquisition of such information is not obtainable by any other means. In no case should the exposure cause lasting harm to study participants.

      Provide the following for intentional exposure studies:

      1. Justification for exposure: Please provide the scientific background and rationale for the study design, subject selection, and value of the study to public health. Include any information about previous animal studies and (if available) human observational studies that justify the need for exposure research.
      2. Participant Selection and Informed Consent: Describe how subjects will be recruited for the study and how both participant selection and the informed consent process described earlier conform to best practices in exposure research.
      3. Compensation for Research Participation: Describe the amount of compensation being offered to participants, as well as the distribution plan, and justify these practices with respect to best practices in exposure research.
      4. Compensation for Research-Related Injury: Discuss how you plan to ensure that participants receive needed medical care for injuries incurred in the study, without cost to the participants.
      5. Appropriate Review and Oversight: Describe the constitution of the IRB that will review this research and defend its ability to consider whether the study(ies) has the potential of providing a clear health or environmental benefit to the community. In addition, describe the procedures for reporting adverse events or unanticipated problems to the IRB, as well as how these events will be analyzed with respect to risk to subjects.
       

      The EPA HSRRO must also consider the following items to determine if the necessary conditions for scientifically and ethically acceptable intentional human dosing studies have been satisfied in order to approve intentional exposure research:

      • prior animal studies and, if available, human observational studies;
      • a demonstrated need for the knowledge to be obtained from intentional human dosing studies;
      • justification and documentation of a research design and statistical analysis that are appropriate to address an important scientific question, including adequate power to detect appropriate effects;
      • an acceptable balance of risks and benefits, and minimization of risks to participants;
      • equitable selection of participants;
      • free and informed consent of participants; and
      • review by an appropriately constituted IRB.

    4. Data Plan (2 pages)

      Provide a plan to make all data resulting from an agreement under this RFA available in a format and with documentation/metadata such that they may be used by others in the scientific community. This includes data produced under the award, i.e., from observations, analyses, or model development collected or used under the agreement. Applicants who plan to develop or enhance databases containing proprietary or restricted information must provide, within the two pages, a strategy to make the data widely available, while protecting privacy or property rights.

    5. References: References cited are in addition to other page limits (e.g. research plan, quality assurance statement).


  6. Budget and Budget Justification

    1. Budget

      Prepare a master budget table using “SF-424A Budget Information for Non-Construction Programs” (aka SF-424A), available in the Grants.gov electronic application package and also at How to Apply and Required Forms.  Only complete “Section B-Budget Categories”.   Provide the object class budget category (a.-k.) amounts for budget years 1-4 under the Grant Program, Function or Activity heading. Each column reflects a separate budget year. For example, Column (1) reflects budget year 1. Provide a separate 424A with the total budget for years 1-4 in Column (1) and year 5 in Column (2). Column 5 of the second 424A will display the overall project total.

      Applicants may not use subagreements to transfer or delegate their responsibility for successful completion of their EPA assistance agreement.  Please refer to EPA Solicitation Clauses if your organization intends to identify specific contractors, including consultants, and subawardees in your proposal. 

      Please note that institutional cost-sharing is not required. 

    2. Budget Justification [2 pages in addition to the Section IV.C.5. page limitations]

      Describe the basis for calculating the personnel, fringe benefits, travel, equipment, supplies, contractual support, and other costs identified in the SF-424A.  The budget justification should not exceed two consecutively numbered (bottom center), 8.5x11-inch pages of single-spaced, standard 12-point type with 1-inch margins.

      Budget information should be supported at the level of detail described below:

      1. Personnel: List all staff positions by title.  Give annual salary, percentage of time assigned to the project, total cost for the budget period, and project role.  Compensation paid for employees engaged in grant activities must be consistent with payments for similar work within the applicant organization.  Note that for salaries to be allowable as a direct charge to the award, a justification of how that person will be directly involved in the project must be provided. General administrative duties such as answering telephones, filing, typing, or accounting duties are not considered acceptable.

        Below is a sample computation for Personnel:

        Position/Title Annual Salary % of Time Assigned to Project Cost
        Project Manager $70,000 50% $ 35,000
        Env. Specialist $60,000 100% $ 60,000
        Env. Health Tech $45,000 100% $ 45,000
        Total Personnel $140,000

        Note this budget category is limited to persons employed by the applicant organization ONLY.  Those employed elsewhere are classified as subawardees, contractors or consultants. Contractors and consultants should be listed under the “Contractual” budget heading while subawards made to eligible subrecipients are listed under the “Other” budget heading.


      2. Fringe Benefits: Identify the percentage used and the basis for its computation. Fringe benefits are for the personnel listed in budget category (1) above and only for the percentage of time devoted to the project. Fringe benefits include but are not limited to the cost of leave, employee insurance, pensions and unemployment benefit plans.  The applicant should not combine the fringe benefit costs with direct salaries and wages in the personnel category.


      3. Travel: Specify the estimated number of trips, purpose of each trip, number of travelers per trip, destinations, and other costs for each type of travel. Explain the need for any travel, paying particular attention to travel outside the United States.  Include travel funds for annual STAR program progress reviews (estimate for two days in Washington, D.C.) and a final workshop to report on results.

        Below is a sample computation for Travel:

        Purpose of Travel Location Item Computation Cost
        EPA STAR Progress Review DC Lodging 4 people x $100 per night
        x 2 nights
        $800
        Airfare 4 people x $500 round trip $2,000
        Per Diem 4 people x $50 per day
        x 2 days
        $400
        Total Travel $3,200
      4. Equipment: Identify all tangible, non-expendable personal property to be purchased that has an estimated cost of $5,000 or more per unit and a useful life of more than one year. It does not include: (1) equipment planned to be leased/rented, including lease/purchase agreements; or (2) equipment service or maintenance contracts. Details such as the type of equipment, cost, and a brief narrative on the intended use of the equipment for project objectives are required. Each item of equipment must be identified with the corresponding cost. General-purpose equipment (office equipment, etc.) must be justified as to how it will be used on the project. (Property items with a unit cost of less than $5,000 are considered supplies.)


      5. Supplies: “Supplies” means tangible property other than “equipment.” Identify supplies to be used under the project.  This may include: software, office supplies, and laboratory supplies such as reagents, chemicals and glassware. Specifically identify computers to be purchased or upgraded.


      6. Contractual: Specify the purpose of the proposed contract/procurement, the proposed duration of the contract/procurement, the estimated cost, and the proposed procurement method (competitive or non-competitive).  Any procurement of services from individual consultants or commercial firms (including space for workshops) must comply with the competitive procurement requirements of 2 CFR Part 200.317-200.326. Please see EPA Solicitation Clauses for more details.

        Examples of Contractual costs include:

        1. Consultants – Consultants are individuals with specialized skills who are paid     at a daily or hourly rate.  EPA’s participation in the salary rate (excluding overhead) paid to individual consultants retained by recipients or by a recipient's contractors or subcontractors is limited to the maximum daily rate for a Level IV    of the Executive Schedule (formerly GS-18), to be adjusted annually.
        2. Speaker/Trainer Fees – Information on speakers should include the fee and a description of the services they are providing.

      7. Other: List each item in sufficient detail for the EPA to determine the reasonableness of its cost relative to the research to be undertaken. “Other” items may include publication costs, long distance telephone charges, and photocopying costs.  Note that subawards, such as those with other universities or nonprofit research institutions for members of the research team, are included in this category. Provide the total costs proposed for subawards as a separate line item in the budget justification and brief description of the activities to be supported for each subaward or types of subawards if the subrecipients have not been identified. Subawards may not be used to acquire services from consultants or commercial firms. Please see EPA Solicitation Clauses for more details.  The “Other” budget category also includes participant support costs such as stipends or travel assistance for trainees (e.g. interns or fellows).


      8. Indirect Costs: Indirect costs are those incurred by the applicant for a common or joint purpose that benefit more than one cost objective or project, and are not readily assignable to specific cost objectives or projects as a direct cost. In order for indirect costs to be allowable, the applicant must have a negotiated indirect cost rate (e.g., fixed, predetermined, final or provisional), or must have submitted a proposal to their cognizant agency. If indirect costs are included in the budget, identify the cognizant agency and the approved indirect rate.  If your organization does not have a cognizant agency, please note that in the budget justification and provide a brief explanation for how you calculated your indirect cost rate.


  7. Resumes

    Provide resumes for each investigator and important co-worker. You may include resumes from staff of subawardees such as universities. Do not include resumes of consultants or other contractors. The resume is not limited to traditional materials, but should provide materials to clearly and appropriately demonstrate that the investigator has the knowledge needed to perform their component of the proposed research.  The resume for each individual must not exceed two consecutively numbered (bottom center), 8.5x11-inch pages of single-spaced, standard 12-point type with 1-inch margins.

    Alternative to a standard resume, you may use a profile such as an NIH BioSketch that can be generated in SciENcv (see Federal-Wide Researcher Profile Project for information on SciENcv; also see My NCBI Curriculum Vitae Web Application: SciENcv).  These materials should generally conform to the requirements for a resume (e.g., content and page number).

  8. Current and Pending Support

    Complete a current and pending support form (provided at How to Apply and Required Forms) for each investigator and important co-worker.  Do not include current and pending support for consultants or other contractors.  Include all current and pending research regardless of source.

    Note to all prospective applicants requiring multiple Current and Pending Support Form pages: Due to a limitation in Adobe Acrobat's forms functionality, additional pages cannot be directly inserted into the original PDF form and preserve the form data on the subsequent pages. Multiple page form submissions can be created in Acrobat 8 and later using the "PDF Package" option in the "Create PDF from Multiple Files" function. If you have an earlier version of Adobe Standard or Professional, applicants will need to convert each PDF page of the form to an EPS (Encapsulated Post Script) file before creating the PDF for submission.   The following steps will allow applicants with earlier versions of Adobe Standard or Professional to create a PDF package:

    1. Populate the first page of the PDF, and save it as a EPS (Encapsulated Post Script) file.
    2. Reopen the form, and populate it with the data for page 2. Save this page as a different EPS file.  Repeat for as many pages as necessary.
    3. Use Acrobat Distiller to convert the EPS files back to PDF.
    4. Open Acrobat Professional, and combine the individual pages into a combined PDF file.

  9. Guidelines, Limitations, and Additional Requirements

    1. Letters of Intent/Letters of Support

      Letters of intent to provide resources for the proposed research or to document intended interactions are limited to one brief paragraph committing the availability of a resource (e.g., use of a person's time or equipment) or intended interaction (e.g., sharing of data, as-needed consultation) that is described in the Research Plan.  Letters of intent are to be included as an addition to the budget justification documents.  EPA employees are not permitted to provide letters of intent for any application.

      Letters of support do not commit a resource vital to the success of the proposal. A letter of support is written by businesses, organizations, or community members stating their support of the applicant's proposed project.  EPA employees are not permitted to provide letters of support for any application.

      Note:  Letters of intent or support must be part of the application; letters submitted separately will not be accepted.  Any letter of intent or support that exceeds one brief paragraph (excluding letterhead and salutations), is considered part of the Research Plan and is included in the 15-page Research Plan limit.  Any transactions between the successful applicant and parties providing letters of intent or support financed with EPA grant funds are subject to the contract and subaward requirements described here EPA Solicitation Clauses.


    2. Funding Opportunity Number(s) (FON) 

      At various places in the application, applicants are asked to identify the FON. 

      The Funding Opportunity Number for this RFA is:

      Long-term Exposure to Air Pollution and Development of Cardiovascular Disease, EPA-G2016-STAR-B1  


    3. Confidentiality

      By submitting an application in response to this solicitation, the applicant grants the EPA permission to make limited disclosures of the application to technical reviewers both within and outside the Agency for the express purpose of assisting the Agency with evaluating the application.  Information from a pending or unsuccessful application will be kept confidential to the fullest extent allowed under law; information from a successful application may be publicly disclosed to the extent permitted by law.

D. Submission Dates and Times
Applications must be transferred to Grants.gov no later than 11:59:59 pm Eastern Time on the solicitation closing date.  Applications transferred after the closing date and time will be returned to the sender without further consideration.  EPA will not accept any changes to applications after the closing date.

It should be noted that this schedule may be changed without prior notification because of factors not anticipated at the time of announcement.  In the case of a change in the solicitation closing date, a new date will be posted on EPA’s Research Grants website and a modification posted on Grants.gov. 

Solicitation Closing Date: August 2, 2016, 11:59:59 pm Eastern Time (applications must be submitted to Grants.gov by this time, see Section IV.F “Submission Instructions and Other Submission Requirements” for further information).

NOTE: Customarily, applicants are notified about evaluation decisions within six months of the solicitation closing date.  Awards are generally made 9-12 months after the solicitation closing date.

E. Funding Restrictions
The funding mechanism for all awards issued under STAR solicitations will consist of assistance agreements from the EPA.  All award decisions are subject to the availability of funds.  In accordance with the Federal Grant and Cooperative Agreement Act, 31 U.S.C. 6301 et seq., the primary purpose of an assistance agreement is to accomplish a public purpose of support or stimulation authorized by federal statute, rather than acquisition for the direct benefit or use of the Agency.  In issuing a grant, the EPA anticipates that there will be no substantial EPA involvement in the design, implementation, or conduct of the research.  However, the EPA will monitor research progress through annual reports provided by grantees and other contacts, including site visits, with the Principal Investigator(s).

EPA award recipients may incur allowable project costs 90 calendar days before the Federal awarding agency makes the Federal award. Expenses more than 90 calendar days pre-award require prior approval of EPA. All costs incurred before EPA makes the award are at the recipient's risk. EPA is under no obligation to reimburse such costs if for any reason the recipient does not receive a Federal award or if the Federal award is less than anticipated and inadequate to cover such costs.

If you wish to submit applications for more than one STAR funding opportunity you must ensure that the research proposed in each application is significantly different from any other that has been submitted to the EPA or from any other financial assistance you are currently receiving from the EPA or other federal government agency.

Collaborative applications involving more than one institution must be submitted as a single administrative package from one of the institutions involved.

Each proposed project must be able to be completed within the project period and with the initial award of funds.  Applicants should request the entire amount of money needed to complete the project.  Recipients should not anticipate additional funding beyond the initial award of funds for a specific project. 

F. Submission Instructions and Other Submission Requirements
Please read this entire section before attempting an electronic submission through Grants.gov. 

If you do not have the technical capability to utilize the Grants.gov application submission process for this solicitation, see Section IV.A above for additional guidance and instructions.

Note:  Grants.gov submission instructions are updated on an as-needed basis.  Please provide your Authorized Organizational Representative (AOR) with a copy of the following instructions to avoid submission delays that may occur from the use of outdated instructions.

  1. Preparing for Submission.  The electronic submission of your application must be made by an official representative of your institution who is registered with Grants.gov and is authorized to sign applications for Federal assistance.  For more information on the registration requirements that must be completed in order to submit an application through Grants.gov, go to Grants.gov and click on “Register” at the top right corner of the page.  If your organization is not currently registered with Grants.gov, please encourage your office to designate an Authorized Organization Representative (AOR) and ask that individual to begin the registration process as soon as possible. Please note that the registration process also requires that your organization have a unique entity identifier (formerly ‘DUNS’ number) and a current registration with the System for Award Management (SAM) and the process of obtaining both could take a month or more.  Applicants must ensure that all registration requirements are met in order to apply for this opportunity through Grants.gov and should ensure that all such requirements have been met well in advance of the submission deadline.  Registration on Grants.gov, SAM.gov, and unique entity identifier assignment is FREE.

    Applicants need to ensure that the AOR who submits the application through Grants.gov and whose DUNS number is listed on the application is an AOR for the applicant listed on the application. Additionally, the DUNS number listed on the application must be registered to the applicant organization’s SAM account. If not, the application may be deemed ineligible.

    To begin the application process under this grant announcement, go to Grants.gov and click on “Applicants” on the top of the page and then “Apply for Grants” from the drop-down menu and then follow the instructions accordingly. Please note: To apply through Grants.gov, you must use Adobe Reader software and download the compatible Adobe Reader version. For more information about Adobe Reader, to verify compatibility, or to download the free software, please visit Grants.gov Support

    You may also be able to access the application package for this announcement by searching for the opportunity on Grants.gov.  Go to Grants.gov and then click on “Search Grants” at the top of the page and enter the Funding Opportunity Number, EPA-G2016-STAR-B1, or the CFDA number that applies to the announcement (CFDA 66.509), in the appropriate field and click the Search button.  Alternatively, you may be able to access the application package by clicking on the Package button at the top right of the synopsis page for the announcement on Grants.gov.  To find the synopsis page, go to Grants.gov and click “Browse Agencies” in the middle of the page and then go to “Environmental Protection Agency” to find the EPA funding opportunities.

  2. Acknowledgement of Receipt.  The complete application must be transferred to Grants.gov no later than 11:59:59 pm Eastern Time on the solicitation closing date (see “Submission Dates and Times”).  Applications submitted through Grants.gov will be time and date stamped electronically.  Grants.gov provides an on-screen notification of successful initial transfer as well as an email notification of successful transfer from Grants.gov to EPA.  While it is advisable to retain copies of these Grants.gov acknowledgements to document submission, the only official documentation that the application has been received by NCER is the email acknowledgement sent by NCER to the Lead/Contact PI and the Administrative Contact.  This email will be sent from receipt.application@epa.gov; emails to this address will not be accepted.  If an email acknowledgment from receipt.application@epa.gov has not been received within 10 calendar days of the solicitation closing date, immediately inform the Electronic Submissions Contact shown in this solicitation.  Failure to do so may result in your application not being reviewed.

  3. Application Package Preparation.  Your organization’s AOR must submit your complete application package electronically to EPA through Grants.gov (Grants.gov) no later than August 2, 2016, 11:59:59 pm Eastern Time. Please allow for enough time to successfully submit your application and allow for unexpected errors that may require you to resubmit.    

    Please submit all of the application materials described below using the Grants.gov application package that you downloaded using the instructions above. For additional instructions on completing and submitting the electronic application package, click on the “Show Instructions” tab that is accessible within the application package itself. 

    The application package consists of the following mandatory documents. 

    1. Application for Federal Assistance (SF 424):  Complete the form except for the “competition ID” field.
    2. EPA Key Contacts Form 5700-54:  Complete the form.  If additional pages are needed, see (d) below.
    3. SF-424A Budget Information for Non-Construction Programs: Only complete “Section B-Budget Categories”.  Provide the object class budget category (a.-k.) amounts for budget years 1-4 under the Grant Program, Function or Activity heading. Each column reflects a separate budget year. For example, Column (1) reflects budget year 1. Provide a separate 424A with the total budget for years 1-4 in Column (1) and year 5 in Column (2). Column 5 of the second 424A will display the overall project total.
    4. Project Narrative Attachment Form (click on “Add Mandatory Project Narrative”):  Attach a single electronic PDF file labeled “Application” that contains the items described in Section IV.C.3. through IV.C.9.a [Table of Contents, Abstract, Research Plan, Quality Assurance Statement, Human Subjects Research Statement, Data Plan, References, Budget Justification, Resumes, Current and Pending Support, and Letters of Intent/Support] of this solicitation.  In order to maintain format integrity, this file must be submitted in Adobe Acrobat PDF.  Please review the PDF file for conversion errors prior to including it in the electronic application package; requests to rectify conversion errors will not be accepted if made after the solicitation closing date and time. If Key Contacts Continuation pages (see How to Apply and Required Forms) are needed, place them before the Table of Contents (Section IV.C.3.).
     

    Once the application package has been completed, the “Submit” button should be enabled.  If the “Submit” button is not active, please call Grants.gov for assistance at 1-800-518-4726.  Applicants who are outside the U.S. at the time of submittal and are not able to access the toll-free number may reach a Grants.gov representative by calling 606-545-5035.  Investigators should save the completed application package with two different file names before providing it to the AOR to avoid having to re-create the package should submission problems be experienced or a revised application needs to be submitted.  Note:  Revised applications must be submitted before the solicitation closing date and time.

  4. Submitting the application.  The application package must be transferred to Grants.gov by an AOR.  The AOR should close all other software before attempting to submit the application package.  Click the “submit” button of the application package. Your Internet browser will launch and a sign-in page will appear.  Note:  Minor problems are not uncommon with transfers to Grants.gov.  It is essential to allow sufficient time to ensure that your application is submitted to Grants.gov BEFORE 11:59:59 pm Eastern Time on the solicitation closing date.  The Grants.gov support desk operates 24 hours a day, seven days a week, except Federal Holidays.

    A successful transfer will end with an on-screen acknowledgement.  For documentation purposes, print or screen capture this acknowledgement.  If a submission problem occurs, reboot the computer – turning the power off may be necessary – and re-attempt the submission. 

    Note:  Grants.gov issues a “case number” upon a request for assistance.

  5. Transmission Difficulties.  If transmission difficulties that result in a late transmission, no transmission, or rejection of the transmitted application are experienced, and following the above instructions do not resolve the problem so that the application is submitted to Grants.gov by the deadline date and time, follow the guidance below.  The Agency will make a decision concerning each late submission on a case-by-case basis as to whether it should be forwarded for peer review.  All emails, as described below, are to be sent to Debra M. Jones with the FON in the subject line.

    Be aware that EPA will only consider accepting applications that were unable to transmit due to Grants.gov or relevant Sam.gov system issues or for unforeseen exigent circumstances, such as extreme weather interfering with internet access. Failure of an applicant to submit timely because they did not properly or timely register in SAM.gov or Grants.gov is not an acceptable reason to justify acceptance of a late submittal.

    Please note that if the application you are submitting is greater than 70 MB in size, please call or send an email message to the Electronic Submissions Contact listed for this RFA.  The Agency may experience technical difficulty downloading files of this size from Grants.gov.  Therefore, it is important that the Agency verify that the file can be downloaded.  The Agency will provide alternate submission instructions if the file cannot be downloaded.

    1. If you are experiencing problems resulting in an inability to upload the application to Grants.gov, it is essential to call Grants.gov for assistance at 1-800-518-4726 before the application deadline.  Applicants who are outside the U.S. at the time of submittal and are not able to access the toll-free number may reach a Grants.gov representative by calling 606-545-5035.  Be sure to obtain a case number from Grants.gov. If the problems stem from unforeseen exigent circumstances unrelated to Grants.gov, such as extreme weather interfering with internet access, contact Debra M. Jones.
    2. Unsuccessful transfer of the application package: If a successful transfer of the application cannot be accomplished even with assistance from Grants.gov due to electronic submission issues or unforeseen exigent circumstances, send an email message to Debra M. Jones by 11:59:59 pm Eastern Time on the solicitation closing date. The email message must document the problem and include the Grants.gov case number as well as the entire application in PDF format as an attachment.
    3. Grants.gov rejection of the application package:  If a notification is received from Grants.gov stating that the application has been rejected for reasons other than late submittal, promptly send an email to Debra M. Jones with the FON in the subject line within one business day of the closing date of this solicitation.  The email should include any materials provided by Grants.gov and attach the entire application in PDF format.

V. APPLICATION REVIEW INFORMATION

A. Peer Review
All eligible grant applications are reviewed by appropriate external technical peer reviewers   based on the criteria and process described below.  This review is designed to evaluate each application according to its scientific merit.  The individual external peer reviewers include non-EPA scientists, engineers, social scientists, and/or economists who are accomplished in their respective disciplines and proficient in the technical subjects they are reviewing.

Prior to the external technical peer review panel meeting, all reviewers will receive electronic copies of all applications, as well as a full set of abstracts for the applications. Each application will be assigned to a minimum of three primary peer reviewers, one of whom will be assigned the role of Rapporteur. Each reviewer will be assigned up to approximately 10 applications on which to serve as a primary reviewer. During the review period leading up to the panel meeting, primary reviewers will read the full set of abstracts and entire application package for each application they are assigned. They will also prepare a written individual evaluation for each assigned application that addresses the peer review criteria described below and rate the application with a score of excellent, very good, good, fair, or poor. 

At the beginning of the panel meeting, each primary reviewer will report their ratings for the applications they reviewed.  Those applications receiving at least two ratings of Very Good or one rating of Excellent from among the primary reviewers will then be further discussed by the panel in terms of the peer review criteria below.  In addition, if there is one Very Good rating among the primary reviewers of an application, the primary reviewer, whose initial rating is the Very Good, may request discussion of the application by the peer review panel.  All other applications will be declined for further consideration.

After the discussion of an application by the panel, the primary reviewers may revise their initial ratings and if they do so, this will also be documented. The final ratings of the primary reviewers will then be translated by EPA into the final peer review score (excellent, very good, good, fair, or poor) for the application. This is reflected in a peer review results document developed by the Rapporteur which combines the individual initial and final evaluations of the primary reviewers and captures any substantive comments from the panel discussion. This score will be used to determine which applications undergo the internal programmatic review discussed below.  A peer review results document is also developed for applications that are not discussed.  However, this document is a consolidation of the individual primary reviewer initial evaluations, with an average of the scores assigned by the primary reviewers.  

Peer reviewers consider an application’s merit based on the extent to which their application demonstrates the criteria below. Criteria are listed in descending order of importance (i.e., Criteria 1 has the heaviest weight).

  1. Research Merits (subcriteria are in descending order of importance):
    1. The degree to which the application demonstrates that the research is original and contributes to the scientific knowledge in the topic area.  And the degree to which the application demonstrates that the project (and its approach) is defensible and technically feasible, and uses appropriate and adequate research methods. 
    2. The degree to which the application demonstrates that the project results will produce benefits to the public (such as improvements to the environment or human health) and will be disseminated to enhance scientific and technological understanding.
  2. Responsiveness: The degree to which the application demonstrates that the research is responsive to the objectives, research needs, and special considerations specified by the RFA. Proposals are most responsive to this RFA if they satisfactorily address at least three of the research areas identified in Section I.D and those that do so may be rated more highly than those that do not.  Also, proposals that address all four of the research areas will not necessarily be rated more highly than those that address at least three of the areas.
  3. Project Management (subcriteria are equally weighted):
    1. Investigators: The degree to which the application demonstrates that the Principal Investigator(s) and other key personnel have the appropriate qualifications (including research training, demonstrated knowledge of pertinent literature, experience, and publication records).
    2. Management: The degree to which the application demonstrates that the project will be adequately managed to ensure the timely and successful achievement of objectives using appropriate project schedules and milestones.  And the degree to which the application demonstrates the applicant will adequately track and measure progress toward achieving expected results (outputs and outcomes). 
    3. Quality Assurance (QA): The degree to which the application includes an appropriate and adequate QA Statement.
    4. Resources and Cost Controls: The degree to which the application demonstrates that the facilities, equipment, and budget are appropriate, adequate, and available.  And the degree to which the application demonstrates that well-defined and acceptable approaches, procedures, and controls are used to ensure timely and efficient expenditure of awarded grant funds.
  4. Innovation: The degree to which the application demonstrates that the research will challenge and seek to shift current research or engineering paradigms by using innovative theoretical concepts, approaches or methodologies, instrumentation or interventions applicable to one or more fields of research.

B. Programmatic Review
Applications receiving final peer review scores of excellent or very good will then undergo an internal programmatic review, as described below, conducted by experts from the EPA, including individuals from the Office of Research and Development (ORD) and program and regional offices involved with the science or engineering proposed.  All other applications are automatically declined.

Those applicants who received final scores of excellent or very good as a result of the peer review process will be asked to provide additional information for the programmatic review pertaining to the proposed Lead PI’s (in the case of Multiple-PI applications, the Contact PI’s) "Past Performance and Reporting History."  The applicant must provide the EPA Project Officer with information on the proposed Lead/Contact PI's past performance and reporting history under prior Federal agency assistance agreements (assistance agreements include grants and cooperative agreements but not contracts) in terms of: (i) the level of success in managing and completing each agreement, and (ii) history of meeting the reporting requirements under each agreement.

This information is required only for the proposed Lead/Contact PI's performance under Federal assistance agreements initiated within the last three years that were similar in size and scope to the proposed project. 

The specific information required for each agreement is shown below, and must be provided within one week of EPA's request.  A maximum of three pages will be permitted for the response; excess pages will not be reviewed.  Note: If no prior past performance information and/or reporting history exists, you will be asked to so state.

  1. Name of Granting Agency.
  2. Grant/Cooperative agreement number.
  3. Grant/Cooperative agreement title.
  4. Brief description of the grant/cooperative agreement.
  5. A description of how the agreement is similar in size and scope to the proposed project and whether or not it was successfully managed and completed; if not successfully managed and completed, provide an explanation.
  6. Information relating to the proposed Lead/Contact PI's past performance in reporting on progress towards achieving the expected results (outputs/outcomes) under the agreement.  Include the history of submitting timely progress/final technical reports, describe how progress towards achieving the expected results was reported/documented, and if such progress was not being made, provide an explanation of whether, and how, this was reported. 
  7. Total (all years) grant/cooperative agreement dollar value.
  8. Project period.
  9. Technical contact (project officer), telephone number, and Email address (if available).

The purpose of the programmatic review is to ensure an integrated research portfolio for the Agency and help determine which applications to recommend for award.  In conducting the programmatic review, the EPA will consider information provided by the applicant and may consider information from other sources, including prior and current grantors and agency files.

The internal programmatic review panel will assess the following [criteria are listed in descending order of importance (i.e., Criteria 1 has the heaviest weight)]:

  1. The relevance of the proposed science to EPA research priorities.
  2. The proposed Lead/Contact PI's past performance under Federal agency assistance agreements (assistance agreements include grants and cooperative agreements but not contracts) initiated within the last three years that were similar in size and scope to the proposed project in two areas:  First, in successfully managing and completing these prior Federal assistance projects, including whether there is a satisfactory explanation for any lack of success.  Second, in reporting progress toward achieving results (outputs/outcomes) under these agreements, including the proposed Lead/Contact PI's history of submitting timely progress/final technical reports that adequately describe the progress toward achieving the expected results under the agreements.  Any explanation of why progress toward achieving the results was not made will also be considered.  Applicants whose proposed Lead PI/Contact PI has no relevant past performance and/or reporting history, or for whom this information is not available, will be evaluated neither favorably nor unfavorably on these elements.

C. Human Subjects Research Statement (HSRS) Review
Applications being considered for funding after the Programmatic Review that involve human subjects research studies will have their HSRS reviewed by EPA’s HSRRO prior to award. The HSRRO will review the information provided in the HSRS and the Research Plan to determine if the ethical treatment of human subjects is described in a manner appropriate for conditional approval to be granted.

D. Funding Decisions
Final funding decisions are made by the NCER Director based on the results of the peer review and the internal programmatic review and, where applicable, the EPA HSRRO’s assessment of the applicant’s human subjects research (see Section IV.C.5.c). In addition, in making the final funding decisions, the NCER Director may also consider program balance and available funds. Applicants selected for funding will be required to provide additional information listed below under “Award Notices.” The application will then be forwarded to EPA’s Grants and Interagency Agreement Management Division for award in accordance with the EPA’s procedures.

E. Additional Provisions for Applicants Incorporated into the Solicitation
Additional provisions that apply to this solicitation and/or awards made under this solicitation including the clause on Reporting and Use of Information Concerning Recipient Integrity and Performance can be found at EPA Solicitation Clauses. These, and the other provisions that can be found at the website link, are important, and applicants must review them when preparing proposals for this solicitation.   If you are unable to access these provisions electronically at the website above, please communicate with the EPA contact listed in this solicitation to obtain the provisions.

VI. AWARD ADMINISTRATION INFORMATION

A. Award Notices
Customarily, applicants are notified about evaluation decisions within six months of the solicitation closing date.  A Peer Review Results document summarizing the scientific review  will be provided to each applicant with an award or declination letter. 

Applicants to be recommended for funding will be required to submit additional certifications and an electronic version of the revised project abstract.  They may also be asked to provide responses to comments or suggestions offered by the peer reviewers and/or submit a revised budget.  EPA Project Officers will contact the Lead PI/Contact PI to obtain these materials.  Before or after an award, applicants may be required to provide additional quality assurance documentation.

The official notification of an award will be made by the Agency’s Grants and Interagency Agreement Management Division.  Applicants are cautioned that only a grants officer is authorized to bind the Government to the expenditure of funds; preliminary selection by the NCER Director in the Office of Research and Development does not guarantee an award will be made.  For example, statutory authorization, funding, or other issues discovered during the award process may affect the ability of EPA to make an award to an applicant.  The award notice, signed by an EPA grants officer, is the authorizing document and will be provided through electronic or postal mail.

B. Disputes
Disputes related to this assistance agreement competition will be resolved in accordance with the dispute resolution procedures set forth in 70 FR 3629, 3630 (January 26, 2005) which can be found at Grant Competition Dispute Resolution Procedures.  Questions regarding disputes may be referred to the Eligibility Contact identified below.

C. Administrative and National Policy Requirements
Additional provisions that apply to this solicitation and/or awards made under this solicitation, including but not limited to those related to unique entity identifier, SAM, copyrights, disputes, and administrative capability, can be found at EPA Solicitation Clauses

These, and the other provisions that can be found at the website link, are important, and applicants must review them when preparing applications for this solicitation.  If you are unable to access these provisions electronically at the website above, please communicate with the EPA contact listed in this solicitation to obtain the provisions.

Expectations and responsibilities of NCER grantees and cooperative agreement holders are summarized in this section, although the terms grant and grantee are used. 

  1. Meetings: Principal Investigators will be expected to budget for, and participate in, All-Investigators Meetings (also known as progress reviews) approximately once per year with EPA scientists and other grantees to report on research activities and discuss issues of mutual interest. 

  2. Approval of Changes after Award: Prior written approval of changes may be required from EPA. Examples of these changes are contained in 2 CFR 200.308.  Note: prior written approval is also required from the EPA Award Official for incurring costs more than 90 calendar days prior to award.

  3. Human Subjects:
    A grant applicant must agree to comply with all applicable provisions of EPA Regulation 40 CFR Part 26 (Protection of Human Subjects).  In addition, grant applicants must agree to comply with EPA’s procedures for oversight of the recipient’s compliance with 40 CFR Part 26, as given in EPA Order 1000.17A (Policy and Procedures on Protection of Human Research Subjects in EPA Conducted or Supported Research).  As per this Order, no human subject may be involved in any research conducted under this assistance agreement, including recruitment, until the research has been approved or determined to be exempt by the EPA Human Subjects Research Review Official (HSRRO) after review of the approval or exemption determination of the Institutional Review Board(s) (IRB(s)) with jurisdiction over the research under 40 CFR Part 26. Following the initial approvals indicated above, the recipient must, as part of the annual report(s), provide evidence of continuing review and approval of the research by the IRB(s) with jurisdiction, as required by 40 CFR 26.109(e).

    Guidance for investigators conducting EPA-funded research involving human subjects may be obtained here:
    Basic Information about Human Subjects Research
    Basic EPA Policy for Protection of Subjects in Human Research Conducted or Supported by EPA

  4. Data Access and Information Release: After award, all data produced under the award must be made available to the NCER Project Officer without restriction and be accompanied by comprehensive metadata documentation adequate for specialists and non-specialists alike to be able to understand how and where the data were obtained and to evaluate the quality of the data.  If requested, the data products and their metadata must be provided to the NCER Project Officer in a standard exchange format no later than the due date of the grant's final report or the publication of the data product's associated results, whichever comes first.

    Congress, through OMB, has instructed each federal agency to implement Information Quality Guidelines designed to "provide policy and procedural guidance...for ensuring and maximizing the quality, objectivity, utility, and integrity of information, including statistical information, disseminated by Federal agencies." The EPA's implementation may be found at Guidelines for Ensuring and Maximizing the Quality, Objectivity, Utility and Integrity of Information Disseminated by the Environmental Protection Agency.  These procedures may apply to data generated by grant recipients if those data are disseminated as described in the Guidelines.

  5. Reporting: 

    A grant recipient must agree to provide annual performance progress reports, with associated summaries, and a final report with an executive summary.  The summaries will be posted on EPA’s Research Grants website. The reports and summaries should be submitted electronically to the Technical Contact named in Section VII of this announcement.

    A grant recipient must agree to provide copies of any peer reviewed journal article(s) resulting from the research during the project period.  In addition, the recipient should notify the NCER Project Officer of any papers published after completion of the grant that were based on research supported by the grant.  NCER posts references to all publications resulting from a grant on EPA’s Research Grants website.

  6. Acknowledgement of EPA Support: EPA’s full or partial support must be acknowledged in journal articles, oral or poster presentations, news releases, interviews with reporters and other communications.  Any documents developed under this agreement that are intended for distribution to the public or inclusion in a scientific, technical, or other journal shall include the following statement:

    This publication [article] was developed under Assistance Agreement No.________ awarded by the U.S. Environmental Protection Agency to [name of recipient].  It has not been formally reviewed by EPA.  The views expressed in this document are solely those of [name of recipient or names of authors] and do not necessarily reflect those of the Agency.  EPA does not endorse any products or commercial services mentioned in this publication.

VII. AGENCY CONTACTS

Further information, if needed, may be obtained from the EPA contacts indicated below. Information regarding this RFA obtained from sources other than these Agency Contacts may not be accurate. Email inquiries are preferred.

Technical Contact: Vito Ilacqua (ilacqua.vito@epa.gov); phone: 202-564-4512
Eligibility Contact: Ron Josephson (josephson.ron@epa.gov); phone: 202-564-7823
Electronic Submissions: Debra M. Jones (jones.debram@epa.gov); phone: 202-564-7839